Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


Articles published in J Neurooncol

Retrieve available abstracts of 557 articles:
HTML format
Text format



Single Articles


    September 2018
  1. CIESIELSKI MJ, Bu Y, Munich SA, Teegarden P, et al
    KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma.
    J Neurooncol. 2018 Sep 20. pii: 10.1007/s11060-018-2992.
    PubMed     Text format     Abstract available


  2. VAN NIEUWENHUIZEN D, Douw L, Klein M, Peerdeman SM, et al
    Cognitive functioning and functional brain networks in postoperative WHO grade I meningioma patients.
    J Neurooncol. 2018 Sep 15. pii: 10.1007/s11060-018-2987.
    PubMed     Text format     Abstract available


  3. HUA L, Zhu H, Deng J, Tian M, et al
    Clinical and prognostic features of spinal meningioma: a thorough analysis from a single neurosurgical center.
    J Neurooncol. 2018 Sep 12. pii: 10.1007/s11060-018-2993.
    PubMed     Text format     Abstract available


  4. KLINE C, Liu SJ, Duriseti S, Banerjee A, et al
    Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience.
    J Neurooncol. 2018 Sep 11. pii: 10.1007/s11060-018-2991.
    PubMed     Text format     Abstract available


  5. DING X, Wang Z, Chen D, Wang Y, et al
    The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma: a multicenter retrospective study.
    J Neurooncol. 2018 Sep 11. pii: 10.1007/s11060-018-2985.
    PubMed     Text format     Abstract available


  6. HEILAND DH, Haaker G, Watzlawick R, Delev D, et al
    Correction to: One decade of glioblastoma multiforme surgery in 342 elderly patients: what have we learned?
    J Neurooncol. 2018 Sep 10. pii: 10.1007/s11060-018-2994.
    PubMed     Text format     Abstract available


  7. WIRSCHING HG, Richter JK, Sahm F, Morel C, et al
    Post-operative cardiovascular complications and time to recurrence in meningioma patients treated with versus without pre-operative embolization: a retrospective cohort study of 741 patients.
    J Neurooncol. 2018 Sep 8. pii: 10.1007/s11060-018-2996.
    PubMed     Text format     Abstract available


  8. SADIK ZHA, Hanssens PEJ, Verheul JB, Beute GN, et al
    Gamma knife radiosurgery for recurrent gliomas.
    J Neurooncol. 2018 Sep 6. pii: 10.1007/s11060-018-2988.
    PubMed     Text format     Abstract available


  9. QUAN G, Zheng Y, Chen J, Hua B, et al
    Prediction value of unmeasurable MR enhancement at early stage after gross-total resection on the survival state of patients with high-grade glioma.
    J Neurooncol. 2018 Sep 4. pii: 10.1007/s11060-018-2961.
    PubMed     Text format     Abstract available


  10. PALMER JD, Bhamidipati D, Song A, Eldredge-Hindy HB, et al
    Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
    J Neurooncol. 2018 Sep 4. pii: 10.1007/s11060-018-2989.
    PubMed     Text format     Abstract available


  11. MARGOL AS, Yeo KK, Xia C, Onar A, et al
    A comparative analysis of clinicopathological features and survival among early adolescents/young adults and children with low-grade glioma: a report from the Children's Oncology Group.
    J Neurooncol. 2018 Sep 1. pii: 10.1007/s11060-018-2983.
    PubMed     Text format     Abstract available


    August 2018
  12. TAYLOR JW, Parikh M, Phillips JJ, James CD, et al
    Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma.
    J Neurooncol. 2018 Aug 27. pii: 10.1007/s11060-018-2977.
    PubMed     Text format     Abstract available


  13. DITMER A, Zhang B, Shujaat T, Pavlina A, et al
    Diagnostic accuracy of MRI texture analysis for grading gliomas.
    J Neurooncol. 2018 Aug 25. pii: 10.1007/s11060-018-2984.
    PubMed     Text format     Abstract available


  14. GARNER EF, Stafman LL, Williams AP, Aye JM, et al
    UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts.
    J Neurooncol. 2018 Aug 21. pii: 10.1007/s11060-018-2950.
    PubMed     Text format     Abstract available


  15. DE CARLO E, Gerratana L, De Maglio G, Buoro V, et al
    Defining a prognostic score based on O6-methylguanine-DNA methyltransferase cut-off methylation level determined by pyrosequencing in patients with glioblastoma multiforme.
    J Neurooncol. 2018 Aug 21. pii: 10.1007/s11060-018-2981.
    PubMed     Text format     Abstract available


  16. RICE SR, Bentzen SM, Hanna A, Choi E, et al
    Prognostic models for patients with brain metastases after stereotactic radiosurgery with or without whole brain radiotherapy: a validation study.
    J Neurooncol. 2018 Aug 21. pii: 10.1007/s11060-018-2958.
    PubMed     Text format     Abstract available


  17. ROBERTS NB, Alqazzaz A, Hwang JR, Qi X, et al
    Oxaliplatin disrupts pathological features of glioma cells and associated macrophages independent of apoptosis induction.
    J Neurooncol. 2018 Aug 21. pii: 10.1007/s11060-018-2979.
    PubMed     Text format     Abstract available


  18. CLARK AR, Calligaris D, Regan MS, Pomeranz Krummel D, et al
    Rapid discrimination of pediatric brain tumors by mass spectrometry imaging.
    J Neurooncol. 2018 Aug 20. pii: 10.1007/s11060-018-2978.
    PubMed     Text format     Abstract available


  19. GEORGAKIS MK, Tsivgoulis G, Spinos D, Dimitriou NG, et al
    Clinical, neuroimaging and histopathological features of gliomatosis cerebri: a systematic review based on synthesis of published individual patient data.
    J Neurooncol. 2018 Aug 16. pii: 10.1007/s11060-018-2976.
    PubMed     Text format     Abstract available


  20. YUAN Z, Zhao L, Zhang Y, Li S, et al
    Inhibition of glioma growth by a GOLPH3 siRNA-loaded cationic liposomes.
    J Neurooncol. 2018 Aug 13. pii: 10.1007/s11060-018-2966.
    PubMed     Text format     Abstract available


  21. KOO T, Lim DH, Seol HJ, Dho YS, et al
    Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.
    J Neurooncol. 2018 Aug 10. pii: 10.1007/s11060-018-2972.
    PubMed     Text format     Abstract available


  22. KONDYLI M, Larouche V, Saint-Martin C, Ellezam B, et al
    Trametinib for progressive pediatric low-grade gliomas.
    J Neurooncol. 2018 Aug 10. pii: 10.1007/s11060-018-2971.
    PubMed     Text format     Abstract available


  23. CHOHAN MO, Berger MS
    5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
    J Neurooncol. 2018 Aug 10. pii: 10.1007/s11060-018-2956.
    PubMed     Text format     Abstract available


  24. HAN Y, Xie Z, Zang Y, Zhang S, et al
    Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas.
    J Neurooncol. 2018 Aug 10. pii: 10.1007/s11060-018-2953.
    PubMed     Text format     Abstract available


  25. HASHEMI-SADRAEI N, Muller-Greven GM, Abdul-Karim FW, Ulasov I, et al
    Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancer.
    J Neurooncol. 2018 Aug 9. pii: 10.1007/s11060-018-2959.
    PubMed     Text format     Abstract available


  26. DERKS J, Wesseling P, Carbo EWS, Hillebrand A, et al
    Oscillatory brain activity associates with neuroligin-3 expression and predicts progression free survival in patients with diffuse glioma.
    J Neurooncol. 2018 Aug 9. pii: 10.1007/s11060-018-2967.
    PubMed     Text format     Abstract available


  27. VARGO JA, Sparks KM, Singh R, Jacobson GM, et al
    Feasibility of dose escalation using intraoperative radiotherapy following resection of large brain metastases compared to post-operative stereotactic radiosurgery.
    J Neurooncol. 2018 Aug 9. pii: 10.1007/s11060-018-2968.
    PubMed     Text format     Abstract available


  28. PALMER JD, Bhamidipati D, Mehta M, Williams NL, et al
    Treatment recommendations for elderly patients with newly diagnosed glioblastoma lack worldwide consensus.
    J Neurooncol. 2018 Aug 7. pii: 10.1007/s11060-018-2969.
    PubMed     Text format     Abstract available


  29. PATEL RA, Lock D, Helenowski IB, Chandler JP, et al
    Postoperative stereotactic radiosurgery for patients with resected brain metastases: a volumetric analysis.
    J Neurooncol. 2018 Aug 6. pii: 10.1007/s11060-018-2965.
    PubMed     Text format     Abstract available


  30. BERGER A, Strauss I, Ben Moshe S, Corn BW, et al
    Neurocognitive evaluation of brain metastases patients treated with post-resection stereotactic radiosurgery: a prospective single arm clinical trial.
    J Neurooncol. 2018 Aug 4. pii: 10.1007/s11060-018-2954.
    PubMed     Text format     Abstract available


  31. HEILAND DH, Haaker G, Watzlawik R, Delev D, et al
    One decade of glioblastoma multiforme surgery in 342 elderly patients: what have we learned?
    J Neurooncol. 2018 Aug 3. pii: 10.1007/s11060-018-2964.
    PubMed     Text format     Abstract available


  32. SASAKI T, Fukai J, Kodama Y, Hirose T, et al
    Characteristics and outcomes of elderly patients with diffuse gliomas: a multi-institutional cohort study by Kansai Molecular Diagnosis Network for CNS Tumors.
    J Neurooncol. 2018 Aug 3. pii: 10.1007/s11060-018-2957.
    PubMed     Text format     Abstract available


  33. LUKAS RV, Rodon J, Becker K, Wong ET, et al
    Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma.
    J Neurooncol. 2018 Aug 2. pii: 10.1007/s11060-018-2955.
    PubMed     Text format     Abstract available


  34. SACHER M, Meixensberger J, Krupp W
    Interaction of quality of life, mood and depression of patients and their informal caregivers after surgical treatment of high-grade glioma: a prospective study.
    J Neurooncol. 2018 Aug 2. pii: 10.1007/s11060-018-2962.
    PubMed     Text format     Abstract available


    July 2018
  35. CAI J, Zhang J, Wu P, Yang W, et al
    Blocking LINC00152 suppresses glioblastoma malignancy by impairing mesenchymal phenotype through the miR-612/AKT2/NF-kappaB pathway.
    J Neurooncol. 2018 Jul 24. pii: 10.1007/s11060-018-2951.
    PubMed     Text format     Abstract available


  36. FURTNER J, Berghoff AS, Schopf V, Reumann R, et al
    Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases.
    J Neurooncol. 2018 Jul 14. pii: 10.1007/s11060-018-2948.
    PubMed     Text format     Abstract available


  37. MORALES LA MADRID A, Ranjan S, Warren KE
    Gliomatosis cerebri: a consensus summary report from the Second International Gliomatosis cerebri Group Meeting, June 22-23, 2017, Bethesda, USA.
    J Neurooncol. 2018 Jul 11. pii: 10.1007/s11060-018-2938.
    PubMed     Text format     Abstract available


  38. QIAN Z, Li Y, Ma J, Xue Y, et al
    Prognostic value of NUSAP1 in progression and expansion of glioblastoma multiforme.
    J Neurooncol. 2018 Jul 11. pii: 10.1007/s11060-018-2942.
    PubMed     Text format     Abstract available


  39. D'AMICO RS, Zanazzi G, Wu P, Canoll P, et al
    Pineal region glioblastomas display features of diffuse midline and non-midline gliomas.
    J Neurooncol. 2018 Jul 10. pii: 10.1007/s11060-018-2931.
    PubMed     Text format     Abstract available


  40. FREYSCHLAG CF, Krieg SM, Kerschbaumer J, Pinggera D, et al
    Imaging practice in low-grade gliomas among European specialized centers and proposal for a minimum core of imaging.
    J Neurooncol. 2018 Jul 10. pii: 10.1007/s11060-018-2916.
    PubMed     Text format     Abstract available


  41. DHO YS, Kim YH, Kim JW, Park CK, et al
    Optimal strategy of gamma knife radiosurgery for craniopharyngiomas.
    J Neurooncol. 2018 Jul 9. pii: 10.1007/s11060-018-2943.
    PubMed     Text format     Abstract available


  42. MCCLELLAND S 3RD, Sosanya O, Mitin T, Degnin C, et al
    Application of tumor treating fields for newly diagnosed glioblastoma: understanding of nationwide practice patterns.
    J Neurooncol. 2018 Jul 9. pii: 10.1007/s11060-018-2945.
    PubMed     Text format     Abstract available


  43. MEHREN A, Ozyurt J, Zu Klampen P, Boekhoff S, et al
    Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma.
    J Neurooncol. 2018 Jul 3. pii: 10.1007/s11060-018-2936.
    PubMed     Text format     Abstract available


    June 2018
  44. ISLIM AI, Ali A, Bagchi A, Ahmad MU, et al
    Postoperative seizures in meningioma patients: improving patient selection for antiepileptic drug therapy.
    J Neurooncol. 2018 Jun 29. pii: 10.1007/s11060-018-2941.
    PubMed     Text format     Abstract available


  45. MALDONADO MD, Batchala P, Ornan D, Fadul C, et al
    Features of diffuse gliomas that are misdiagnosed on initial neuroimaging: a case control study.
    J Neurooncol. 2018 Jun 29. pii: 10.1007/s11060-018-2939.
    PubMed     Text format     Abstract available


  46. WONG ET, Swanson KD
    Everolimus shortens survival of newly diagnosed glioblastoma patients.
    J Neurooncol. 2018 Jun 28. pii: 10.1007/s11060-018-2937.
    PubMed     Text format    


  47. MALLICK S, Kunhiparambath H, Gupta S, Benson R, et al
    Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
    J Neurooncol. 2018 Jun 23. pii: 10.1007/s11060-018-2932.
    PubMed     Text format     Abstract available


  48. BAUER-NILSEN K, Trifiletti DM, Chatrath A, Ruiz-Garcia H, et al
    Stereotactic radiosurgery for brain metastases from malignant melanoma and the impact of hemorrhagic metastases.
    J Neurooncol. 2018 Jun 20. pii: 10.1007/s11060-018-2933.
    PubMed     Text format     Abstract available


  49. GILARD V, Goia A, Ferracci FX, Marguet F, et al
    Spinal meningioma and factors predictive of post-operative deterioration.
    J Neurooncol. 2018 Jun 20. pii: 10.1007/s11060-018-2929.
    PubMed     Text format     Abstract available


  50. TANG L, Deng L, Bai HX, Sun J, et al
    Reduced expression of DNA repair genes and chemosensitivity in 1p19q codeleted lower-grade gliomas.
    J Neurooncol. 2018 Jun 19. pii: 10.1007/s11060-018-2915.
    PubMed     Text format     Abstract available


  51. SUN J, Li B, Jia Z, Zhang A, et al
    RUNX3 inhibits glioma survival and invasion via suppression of the beta-catenin/TCF-4 signaling pathway.
    J Neurooncol. 2018 Jun 18. pii: 10.1007/s11060-018-2927.
    PubMed     Text format     Abstract available


  52. CHENG WY, Shen CC, Chiao MT, Liang YJ, et al
    High expression of a novel splicing variant of VEGF, L-VEGF144 in glioblastoma multiforme is associated with a poorer prognosis in bevacizumab treatment.
    J Neurooncol. 2018 Jun 16. pii: 10.1007/s11060-018-2928.
    PubMed     Text format     Abstract available


  53. ROBIN TP, Breeze RE, Smith DE, Rusthoven CG, et al
    Immune checkpoint inhibitors and radiosurgery for newly diagnosed melanoma brain metastases.
    J Neurooncol. 2018 Jun 16. pii: 10.1007/s11060-018-2930.
    PubMed     Text format     Abstract available


  54. MISHKIN B, Raizer JJ, Bell JB
    Widespread disseminated osseous metastases of intracranial meningioma with over 27-year-survivorship: a unique, idiosyncratic case.
    J Neurooncol. 2018 Jun 15. pii: 10.1007/s11060-018-2926.
    PubMed     Text format    


  55. WANK M, Schilling D, Reindl J, Meyer B, et al
    Evaluation of radiation-related invasion in primary patient-derived glioma cells and validation with established cell lines: impact of different radiation qualities with differing LET.
    J Neurooncol. 2018 Jun 8. pii: 10.1007/s11060-018-2923.
    PubMed     Text format     Abstract available


  56. OSORIO DS, Hu J, Mitchell C, Allen JC, et al
    Effect of lapatinib on meningioma growth in adults with neurofibromatosis type 2.
    J Neurooncol. 2018 Jun 8. pii: 10.1007/s11060-018-2922.
    PubMed     Text format     Abstract available


  57. SUCHORSKA B, Unterrainer M, Biczok A, Sosnova M, et al
    (18)F-FET-PET as a biomarker for therapy response in non-contrast enhancing glioma following chemotherapy.
    J Neurooncol. 2018 Jun 8. pii: 10.1007/s11060-018-2919.
    PubMed     Text format     Abstract available


  58. HANSEN MR, Pan E, Wilson A, McCreary M, et al
    Post-gadolinium 3-dimensional spatial, surface, and structural characteristics of glioblastomas differentiate pseudoprogression from true tumor progression.
    J Neurooncol. 2018 Jun 7. pii: 10.1007/s11060-018-2920.
    PubMed     Text format     Abstract available


  59. LI Y, Liu Y, Ren J, Deng S, et al
    miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma.
    J Neurooncol. 2018 Jun 6. pii: 10.1007/s11060-018-2835.
    PubMed     Text format     Abstract available


  60. HASHIMOTO Y, Penas-Prado M, Zhou S, Wei J, et al
    Rethinking medulloblastoma from a targeted therapeutics perspective.
    J Neurooncol. 2018 Jun 5. pii: 10.1007/s11060-018-2917.
    PubMed     Text format     Abstract available


  61. BAHRAMI N, Hartman SJ, Chang YH, Delfanti R, et al
    Molecular classification of patients with grade II/III glioma using quantitative MRI characteristics.
    J Neurooncol. 2018 Jun 2. pii: 10.1007/s11060-018-2908.
    PubMed     Text format     Abstract available


    May 2018
  62. CHAKHOYAN A, Woodworth DC, Harris RJ, Lai A, et al
    Mono-exponential, diffusion kurtosis and stretched exponential diffusion MR imaging response to chemoradiation in newly diagnosed glioblastoma.
    J Neurooncol. 2018 May 31. pii: 10.1007/s11060-018-2910.
    PubMed     Text format     Abstract available


  63. BERGQVIST J, Iderberg H, Mesterton J, Henriksson R, et al
    The effects of clinical and sociodemographic factors on survival, resource use and lead times in patients with high-grade gliomas: a population-based register study.
    J Neurooncol. 2018 May 30. pii: 10.1007/s11060-018-2899.
    PubMed     Text format     Abstract available


  64. EVERSON RG, Hashimoto Y, Freeman JL, Hodges TR, et al
    Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design.
    J Neurooncol. 2018 May 30. pii: 10.1007/s11060-018-2891.
    PubMed     Text format     Abstract available


  65. CHOWDHARY M, Switchenko JM, Press RH, Jhaveri J, et al
    Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery.
    J Neurooncol. 2018 May 30. pii: 10.1007/s11060-018-2914.
    PubMed     Text format     Abstract available


  66. YANG CA, Huang HY, Lin CL, Chang JG, et al
    G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity.
    J Neurooncol. 2018 May 29. pii: 10.1007/s11060-018-2911.
    PubMed     Text format     Abstract available


  67. BICZOK A, Kraus T, Suchorska B, Terpolilli NA, et al
    TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas.
    J Neurooncol. 2018 May 28. pii: 10.1007/s11060-018-2912.
    PubMed     Text format     Abstract available


  68. BAUMGARTEN P, Quick-Weller J, Gessler F, Wagner M, et al
    Pre- and early postoperative GFAP serum levels in glioma and brain metastases.
    J Neurooncol. 2018 May 24. pii: 10.1007/s11060-018-2898.
    PubMed     Text format     Abstract available


  69. THOMPSON EM, Bramall A, Herndon JE 2nd, Taylor MD, et al
    The clinical importance of medulloblastoma extent of resection: a systematic review.
    J Neurooncol. 2018 May 23. pii: 10.1007/s11060-018-2906.
    PubMed     Text format     Abstract available


  70. LIU J, Zheng M, Yang W, Lo SL, et al
    Impact of surgery and radiation therapy on spinal high-grade gliomas: a population-based study.
    J Neurooncol. 2018 May 23. pii: 10.1007/s11060-018-2904.
    PubMed     Text format     Abstract available


  71. FUJIHARA T, Mizobuchi Y, Nakajima K, Kageji T, et al
    Down-regulation of MDR1 by Ad-DKK3 via Akt/NFkappaB pathways augments the anti-tumor effect of temozolomide in glioblastoma cells and a murine xenograft model.
    J Neurooncol. 2018 May 19. pii: 10.1007/s11060-018-2894.
    PubMed     Text format     Abstract available


  72. MANTICA M, Pritchard A, Lieberman F, Drappatz J, et al
    Retrospective study of nivolumab for patients with recurrent high grade gliomas.
    J Neurooncol. 2018 May 19. pii: 10.1007/s11060-018-2907.
    PubMed     Text format     Abstract available


  73. BALANA C, Estival A, Pineda E
    Bevacizumab rechallenge in glioblastoma patients with initial response to bevacizumab who later progress off therapy.
    J Neurooncol. 2018 May 18. pii: 10.1007/s11060-018-2902.
    PubMed     Text format    


  74. EIJGELAAR RS, Bruynzeel AME, Lagerwaard FJ, Muller DMJ, et al
    Earliest radiological progression in glioblastoma by multidisciplinary consensus review.
    J Neurooncol. 2018 May 18. pii: 10.1007/s11060-018-2896.
    PubMed     Text format     Abstract available


  75. ZHANG J, Zhang J, Qiu W, Zhang J, et al
    MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma.
    J Neurooncol. 2018 May 17. pii: 10.1007/s11060-018-2903.
    PubMed     Text format     Abstract available


  76. PHILLIPS M, Saria M, Eisenberg A, Kelly DF, et al
    Safety of commercial airflight in patients with brain tumors: a case series.
    J Neurooncol. 2018 May 17. pii: 10.1007/s11060-018-2905.
    PubMed     Text format     Abstract available


  77. DE LOOZE C, Beausang A, Cryan J, Loftus T, et al
    Machine learning: a useful radiological adjunct in determination of a newly diagnosed glioma's grade and IDH status.
    J Neurooncol. 2018 May 16. pii: 10.1007/s11060-018-2895.
    PubMed     Text format     Abstract available


  78. LU VM, Phan K, Yin JXM, McDonald KL, et al
    Older studies can underestimate prognosis of glioblastoma biomarker in meta-analyses: a meta-epidemiological study for study-level effect in the current literature.
    J Neurooncol. 2018 May 16. pii: 10.1007/s11060-018-2897.
    PubMed     Text format     Abstract available


  79. VOLAK A, LeRoy SG, Natasan JS, Park DJ, et al
    Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery.
    J Neurooncol. 2018 May 16. pii: 10.1007/s11060-018-2889.
    PubMed     Text format     Abstract available


  80. MASSIMINO M, Biassoni V, Miceli R, Schiavello E, et al
    Correction to: Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood.
    J Neurooncol. 2018 May 16. pii: 10.1007/s11060-018-2893.
    PubMed     Text format     Abstract available


  81. UCKERMANN O, Yao W, Juratli TA, Galli R, et al
    IDH1 mutation in human glioma induces chemical alterations that are amenable to optical Raman spectroscopy.
    J Neurooncol. 2018 May 14. pii: 10.1007/s11060-018-2883.
    PubMed     Text format     Abstract available


  82. HANSEN S, Rasmussen BK, Laursen RJ, Kosteljanetz M, et al
    Treatment and survival of glioblastoma patients in Denmark: The Danish Neuro-Oncology Registry 2009-2014.
    J Neurooncol. 2018 May 12. pii: 10.1007/s11060-018-2892.
    PubMed     Text format     Abstract available


  83. KUMAR AMS, Miller J, Hoffer SA, Mansur DB, et al
    Postoperative hypofractionated stereotactic brain radiation (HSRT) for resected brain metastases: improved local control with higher BED10.
    J Neurooncol. 2018 May 10. pii: 10.1007/s11060-018-2885.
    PubMed     Text format     Abstract available


  84. SOIKE MH, McTyre ER, Hughes RT, Farris M, et al
    Initial brain metastasis velocity: does the rate at which cancers first seed the brain affect outcomes?
    J Neurooncol. 2018 May 8. pii: 10.1007/s11060-018-2888.
    PubMed     Text format     Abstract available


  85. HWANG K, Koh EJ, Choi EJ, Kang TH, et al
    PD-1/PD-L1 and immune-related gene expression pattern in pediatric malignant brain tumors: clinical correlation with survival data in Korean population.
    J Neurooncol. 2018 May 5. pii: 10.1007/s11060-018-2886.
    PubMed     Text format     Abstract available


  86. ROMANO A, Pasquini L, Di Napoli A, Tavanti F, et al
    Prediction of survival in patients affected by glioblastoma: histogram analysis of perfusion MRI.
    J Neurooncol. 2018 May 2. pii: 10.1007/s11060-018-2887.
    PubMed     Text format     Abstract available


    April 2018
  87. WU S, Fu J, Dong Y, Yi Q, et al
    GOLPH3 promotes glioma progression via facilitating JAK2-STAT3 pathway activation.
    J Neurooncol. 2018 Apr 30. pii: 10.1007/s11060-018-2884.
    PubMed     Text format     Abstract available


  88. WANG B, Zhao P, Zhang Y, Ge M, et al
    Quantitative dynamic susceptibility contrast perfusion-weighted imaging-guided customized gamma knife re-irradiation of recurrent high-grade gliomas.
    J Neurooncol. 2018 Apr 26. pii: 10.1007/s11060-018-2859.
    PubMed     Text format     Abstract available


  89. DIAO K, Bian SX, Routman DM, Yu C, et al
    Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity.
    J Neurooncol. 2018 Apr 25. pii: 10.1007/s11060-018-2880.
    PubMed     Text format     Abstract available


  90. TOPKAN E, Selek U, Ozdemir Y, Yildirim BA, et al
    Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide.
    J Neurooncol. 2018 Apr 25. pii: 10.1007/s11060-018-2879.
    PubMed     Text format     Abstract available


  91. BRANDEL MG, Rennert RC, Lopez Ramos C, Santiago-Dieppa DR, et al
    Management of glioblastoma at safety-net hospitals.
    J Neurooncol. 2018 Apr 24. pii: 10.1007/s11060-018-2875.
    PubMed     Text format     Abstract available


  92. FARAMAND A, Kano H, Niranjan A, Johnson SA, et al
    Cranial nerve outcomes after primary stereotactic radiosurgery for symptomatic skull base meningiomas.
    J Neurooncol. 2018 Apr 24. pii: 10.1007/s11060-018-2866.
    PubMed     Text format     Abstract available


  93. ZHAO F, Zhang J, Li P, Zhou Q, et al
    Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis.
    J Neurooncol. 2018 Apr 23. pii: 10.1007/s11060-018-2865.
    PubMed     Text format     Abstract available


  94. PATEL CB, Fazzari E, Chakhoyan A, Yao J, et al
    (18)F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naive gliomas: a cross-sectional study.
    J Neurooncol. 2018 Apr 20. pii: 10.1007/s11060-018-2877.
    PubMed     Text format     Abstract available


  95. BARONI M, Marie SKN, Fedatto PF, Andrade AF, et al
    Distinct response to GDF15 knockdown in pediatric and adult glioblastoma cell lines.
    J Neurooncol. 2018 Apr 18. pii: 10.1007/s11060-018-2853.
    PubMed     Text format     Abstract available


  96. FRANCESCHI E, Lamberti G, Paccapelo A, Di Battista M, et al
    Third-line therapy in recurrent glioblastoma: is it another chance for bevacizumab?
    J Neurooncol. 2018 Apr 18. pii: 10.1007/s11060-018-2873.
    PubMed     Text format     Abstract available


  97. HEMPEL JM, Brendle C, Bender B, Bier G, et al
    Contrast enhancement predicting survival in integrated molecular subtypes of diffuse glioma: an observational cohort study.
    J Neurooncol. 2018 Apr 17. pii: 10.1007/s11060-018-2872.
    PubMed     Text format     Abstract available


  98. GUASTELLA AR, Michelhaugh SK, Klinger NV, Fadel HA, et al
    Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors.
    J Neurooncol. 2018 Apr 17. pii: 10.1007/s11060-018-2869.
    PubMed     Text format     Abstract available


  99. JANSSENS GO, Kramm CM, von Bueren AO
    Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients?
    J Neurooncol. 2018 Apr 17. pii: 10.1007/s11060-018-2871.
    PubMed     Text format    


  100. WIJNENGA MMJ, French PJ, Dubbink HJ, Dinjens WNM, et al
    Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma.
    J Neurooncol. 2018 Apr 16. pii: 10.1007/s11060-018-2867.
    PubMed     Text format     Abstract available


  101. ONKEN J, Staub-Bartelt F, Vajkoczy P, Misch M, et al
    Acceptance and compliance of TTFields treatment among high grade glioma patients.
    J Neurooncol. 2018 Apr 11. pii: 10.1007/s11060-018-2858.
    PubMed     Text format     Abstract available


  102. SUNG S, Lee SW, Kwak YK, Kang JH, et al
    Intracranial control and survival outcome of tyrosine kinase inhibitor (TKI) alone versus TKI plus radiotherapy for brain metastasis of epidermal growth factor receptor-mutant non-small cell lung cancer.
    J Neurooncol. 2018 Apr 11. pii: 10.1007/s11060-018-2861.
    PubMed     Text format     Abstract available


  103. MURSCH K
    Information needs and requirements in patients with brain tumours.
    J Neurooncol. 2018 Apr 10. pii: 10.1007/s11060-018-2864.
    PubMed     Text format    


  104. COLEMAN N, Michalarea V, Alken S, Rihawi K, et al
    Safety, efficacy and survival of patients with primary malignant brain tumours (PMBT) in phase I (Ph1) trials: the 12-year Royal Marsden experience.
    J Neurooncol. 2018 Apr 10. pii: 10.1007/s11060-018-2847.
    PubMed     Text format     Abstract available


  105. GUI C, Kosteniuk SE, Lau JC, Megyesi JF, et al
    Tumor growth dynamics in serially-imaged low-grade glioma patients.
    J Neurooncol. 2018 Apr 9. pii: 10.1007/s11060-018-2857.
    PubMed     Text format     Abstract available


  106. VAN WESTRHENEN A, Senders JT, Martin E, DiRisio AC, et al
    Clinical challenges of glioma and pregnancy: a systematic review.
    J Neurooncol. 2018 Apr 6. pii: 10.1007/s11060-018-2851.
    PubMed     Text format     Abstract available


  107. MILLER SE, Tummers WS, Teraphongphom N, van den Berg NS, et al
    First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800.
    J Neurooncol. 2018 Apr 6. pii: 10.1007/s11060-018-2854.
    PubMed     Text format     Abstract available


  108. KOTROTSOU A, Elakkad A, Sun J, Thomas GA, et al
    Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome.
    J Neurooncol. 2018 Apr 4. pii: 10.1007/s11060-018-2850.
    PubMed     Text format     Abstract available


    March 2018
  109. PIPER RJ, Senthil KK, Yan JL, Price SJ, et al
    Neuroimaging classification of progression patterns in glioblastoma: a systematic review.
    J Neurooncol. 2018 Mar 30. pii: 10.1007/s11060-018-2843.
    PubMed     Text format     Abstract available


  110. PACE A, Mandoj C, Antenucci A, Villani V, et al
    A predictive value of von Willebrand factor for early response to Bevacizumab therapy in recurrent glioma.
    J Neurooncol. 2018 Mar 28. pii: 10.1007/s11060-018-2820.
    PubMed     Text format     Abstract available


  111. MEHRABIAN H, Lam WW, Myrehaug S, Sahgal A, et al
    Glioblastoma (GBM) effects on quantitative MRI of contralateral normal appearing white matter.
    J Neurooncol. 2018 Mar 28. pii: 10.1007/s11060-018-2846.
    PubMed     Text format     Abstract available


  112. BEZERRA SALOMAO K, Cruzeiro GAV, Bonfim-Silva R, Geron L, et al
    Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups.
    J Neurooncol. 2018 Mar 26. pii: 10.1007/s11060-018-2845.
    PubMed     Text format     Abstract available


  113. WANG Q, Zhang J, Xu X, Chen X, et al
    Diagnostic performance of apparent diffusion coefficient parameters for glioma grading.
    J Neurooncol. 2018 Mar 24. pii: 10.1007/s11060-018-2841.
    PubMed     Text format     Abstract available


  114. KOO T, Lim DH, Seol HJ, Park CK, et al
    Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.
    J Neurooncol. 2018 Mar 23. pii: 10.1007/s11060-018-2839.
    PubMed     Text format     Abstract available


  115. NOMURA Y, Asano Y, Shinoda J, Yano H, et al
    Characteristics of time-activity curves obtained from dynamic (11)C-methionine PET in common primary brain tumors.
    J Neurooncol. 2018 Mar 21. pii: 10.1007/s11060-018-2834.
    PubMed     Text format     Abstract available


  116. QUAN GM, Zheng YL, Yuan T, Lei JM, et al
    Increasing FLAIR signal intensity in the postoperative cavity predicts progression in gross-total resected high-grade gliomas.
    J Neurooncol. 2018 Mar 21. pii: 10.1007/s11060-018-2758.
    PubMed     Text format     Abstract available


  117. KEIR ST, Chandramohan V, Hemphill CD, Grandal MM, et al
    Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models.
    J Neurooncol. 2018 Mar 21. pii: 10.1007/s11060-018-2832.
    PubMed     Text format     Abstract available


  118. LIM YC, Quek H, Offenhauser C, Fazry S, et al
    ATM inhibition prevents interleukin-6 from contributing to the proliferation of glioblastoma cells after ionizing radiation.
    J Neurooncol. 2018 Mar 21. pii: 10.1007/s11060-018-2838.
    PubMed     Text format     Abstract available


  119. WAKABAYASHI T, Natsume A, Mizusawa J, Katayama H, et al
    JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonbeta plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.
    J Neurooncol. 2018 Mar 20. pii: 10.1007/s11060-018-2831.
    PubMed     Text format     Abstract available


  120. ZHOU C, Wang Y, Liu X, Liang Y, et al
    Molecular profiles for insular low-grade gliomas with putamen involvement.
    J Neurooncol. 2018 Mar 19. pii: 10.1007/s11060-018-2837.
    PubMed     Text format     Abstract available


  121. DREAN A, Rosenberg S, Lejeune FX, Goli L, et al
    Correction to: ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.
    J Neurooncol. 2018 Mar 16. pii: 10.1007/s11060-018-2830.
    PubMed     Text format     Abstract available


  122. WEINBERG BD, Boreta L, Braunstein S, Cha S, et al
    Location of subventricular zone recurrence and its radiation dose predicts survival in patients with glioblastoma.
    J Neurooncol. 2018 Mar 15. pii: 10.1007/s11060-018-2822.
    PubMed     Text format     Abstract available


  123. DUDLEY RWR, Torok MR, Randall S, Beland B, et al
    Pediatric versus adult meningioma: comparison of epidemiology, treatments, and outcomes using the Surveillance, Epidemiology, and End Results database.
    J Neurooncol. 2018 Mar 9. pii: 10.1007/s11060-018-2756.
    PubMed     Text format     Abstract available


  124. MATSUDA M, Ishikawa E, Yamamoto T, Hatano K, et al
    Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with (89)Zr-Df-IAB2M anti-PSMA minibody.
    J Neurooncol. 2018 Mar 9. pii: 10.1007/s11060-018-2825.
    PubMed     Text format     Abstract available


  125. JI C, Guo H, Zhang P, Kuang W, et al
    AnnexinA5 promote glioma cell invasion and migration via the PI3K/Akt/NF-kappaB signaling pathway.
    J Neurooncol. 2018 Mar 8. pii: 10.1007/s11060-018-2818.
    PubMed     Text format     Abstract available


  126. DREAN A, Rosenberg S, Lejeune FX, Goli L, et al
    ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.
    J Neurooncol. 2018 Mar 8. pii: 10.1007/s11060-018-2819.
    PubMed     Text format     Abstract available


  127. ZEMLIN A, Martens B, Wiese B, Merten R, et al
    Timing of re-irradiation in recurrent high-grade gliomas: a single institution study.
    J Neurooncol. 2018 Mar 8. pii: 10.1007/s11060-018-2824.
    PubMed     Text format     Abstract available


  128. IDEGUCHI M, Nishizaki T, Ikeda N, Okamura T, et al
    A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.
    J Neurooncol. 2018 Mar 7. pii: 10.1007/s11060-018-2821.
    PubMed     Text format     Abstract available


  129. REINERT C, Rathberger K, Klinkhammer-Schalke M, Kolbl O, et al
    Information needs and requirements in patients with brain tumours and their relatives.
    J Neurooncol. 2018 Mar 7. pii: 10.1007/s11060-018-2811.
    PubMed     Text format     Abstract available


  130. POUCHIEU C, Raherison C, Piel C, Migault L, et al
    Allergic conditions and risk of glioma and meningioma in the CERENAT case-control study.
    J Neurooncol. 2018 Mar 2. pii: 10.1007/s11060-018-2816.
    PubMed     Text format     Abstract available


  131. CARRABBA G, Riva M, Conte V, Di Cristofori A, et al
    Risk of post-operative venous thromboembolism in patients with meningioma.
    J Neurooncol. 2018 Mar 2. pii: 10.1007/s11060-018-2810.
    PubMed     Text format     Abstract available


    February 2018
  132. DARLIX A, Griguolo G, Thezenas S, Kantelhardt E, et al
    Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer.
    J Neurooncol. 2018 Feb 27. pii: 10.1007/s11060-018-2805.
    PubMed     Text format     Abstract available


  133. CHEN WC, Hara J, Magill ST, Wu A, et al
    Salvage therapy outcomes for atypical meningioma.
    J Neurooncol. 2018 Feb 26. pii: 10.1007/s11060-018-2813.
    PubMed     Text format     Abstract available


  134. MALAKOOTIAN M, Mirzadeh Azad F, Fouani Y, Taheri Bajgan E, et al
    Anti-differentiation non-coding RNA, ANCR, is differentially expressed in different types of brain tumors.
    J Neurooncol. 2018 Feb 23. pii: 10.1007/s11060-018-2809.
    PubMed     Text format     Abstract available


  135. RODENBURG RJ, Hanssens PE, Ho VKY, Beerepoot LV, et al
    Validation of the Chowdhury overall survival score in patients with melanoma brain metastasis treated with Gamma Knife Radiosurgery.
    J Neurooncol. 2018 Feb 22. pii: 10.1007/s11060-018-2808.
    PubMed     Text format     Abstract available


  136. WASCHKE A, Arefian H, Walter J, Hartmann M, et al
    Cost-effectiveness of the long-term use of temozolomide for treating newly diagnosed glioblastoma in Germany.
    J Neurooncol. 2018 Feb 21. pii: 10.1007/s11060-018-2804.
    PubMed     Text format     Abstract available


  137. KIRCHES E, Steffen T, Waldt N, Hebert E, et al
    The expression of the MSC-marker CD73 and of NF2/Merlin are correlated in meningiomas.
    J Neurooncol. 2018 Feb 21. pii: 10.1007/s11060-018-2807.
    PubMed     Text format     Abstract available


  138. GEORGAKIS MK, Spinos D, Pourtsidis A, Psyrri A, et al
    Incidence and survival of gliomatosis cerebri: a population-based cancer registration study.
    J Neurooncol. 2018 Feb 20. pii: 10.1007/s11060-018-2802.
    PubMed     Text format     Abstract available


  139. SEIBL-LEVEN M, von Reeken C, Goldbrunner R, Grau S, et al
    Clinical routine assessment of palliative care symptoms and concerns and caregiver burden in glioblastoma patients: an explorative field study.
    J Neurooncol. 2018 Feb 20. pii: 10.1007/s11060-018-2800.
    PubMed     Text format     Abstract available


  140. BUNEVICIUS A, Radziunas A, Tamasauskas S, Tamasauskas A, et al
    Prognostic role of high sensitivity C-reactive protein and interleukin-6 in glioma and meningioma patients.
    J Neurooncol. 2018 Feb 19. pii: 10.1007/s11060-018-2803.
    PubMed     Text format     Abstract available


  141. RAHMAN R, Cortes A, Niemierko A, Oh KS, et al
    The impact of timing of immunotherapy with cranial irradiation in melanoma patients with brain metastases: intracranial progression, survival and toxicity.
    J Neurooncol. 2018 Feb 16. pii: 10.1007/s11060-018-2795.
    PubMed     Text format     Abstract available


  142. HERSH DS, Peng S, Dancy JG, Galisteo R, et al
    Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas.
    J Neurooncol. 2018 Feb 16. pii: 10.1007/s11060-018-2799.
    PubMed     Text format     Abstract available


  143. PERDOMO-PANTOJA A, Mejia-Perez SI, Gomez-Flores-Ramos L, Lara-Velazquez M, et al
    Renin angiotensin system and its role in biomarkers and treatment in gliomas.
    J Neurooncol. 2018 Feb 16. pii: 10.1007/s11060-018-2789.
    PubMed     Text format     Abstract available


  144. LIMON D, Gal O, Gordon N, Katz L, et al
    Brain metastasis in gastroesophageal adenocarcinoma and HER2 status.
    J Neurooncol. 2018 Feb 10. pii: 10.1007/s11060-018-2798.
    PubMed     Text format     Abstract available


  145. LASTOWSKA M, Trubicka J, Niemira M, Paczkowska-Abdulsalam M, et al
    Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.
    J Neurooncol. 2018 Feb 9. pii: 10.1007/s11060-018-2797.
    PubMed     Text format     Abstract available


  146. HAPPOLD C, Gorlia T, Nabors LB, Erridge SC, et al
    Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?
    J Neurooncol. 2018 Feb 8. pii: 10.1007/s11060-018-2786.
    PubMed     Text format     Abstract available


  147. MISTRY AM, Vnencak-Jones CL, Mobley BC
    Clinical prognostic value of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in glioblastoma.
    J Neurooncol. 2018 Feb 8. pii: 10.1007/s11060-018-2796.
    PubMed     Text format     Abstract available


  148. CHOWDHURY T, Yoo Y, Seo Y, Dho YS, et al
    Genomic analysis of synchronous intracranial meningiomas with different histological grades.
    J Neurooncol. 2018 Feb 8. pii: 10.1007/s11060-018-2772.
    PubMed     Text format     Abstract available


  149. ALI AN, Zhang P, Yung WKA, Chen Y, et al
    NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.
    J Neurooncol. 2018 Feb 5. pii: 10.1007/s11060-017-2558.
    PubMed     Text format     Abstract available


  150. SORENSEN MF, Heimisdottir SB, Sorensen MD, Mellegaard CS, et al
    High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma.
    J Neurooncol. 2018 Feb 5. pii: 10.1007/s11060-018-2785.
    PubMed     Text format     Abstract available


  151. HASAN F, Weingarten K, Rapoport A, Bouffet E, et al
    End-of-life care of children with diffuse intrinsic pontine glioma.
    J Neurooncol. 2018 Feb 3. pii: 10.1007/s11060-018-2781.
    PubMed     Text format     Abstract available


  152. ZUMBAR CT, Usubalieva A, King PD, Li X, et al
    The CNS penetrating taxane TPI 287 and the AURKA inhibitor alisertib induce synergistic apoptosis in glioblastoma cells.
    J Neurooncol. 2018 Feb 2. pii: 10.1007/s11060-018-2755.
    PubMed     Text format     Abstract available


  153. JACKSON WC, Tsien CI, Junck L, Leung D, et al
    Standard dose and dose-escalated radiation therapy are associated with favorable survival in select elderly patients with newly diagnosed glioblastoma.
    J Neurooncol. 2018 Feb 1. pii: 10.1007/s11060-018-2782.
    PubMed     Text format     Abstract available


  154. KARSY M, Yoon N, Boettcher L, Jensen R, et al
    Surgical treatment of glioblastoma in the elderly: the impact of complications.
    J Neurooncol. 2018 Feb 1. pii: 10.1007/s11060-018-2777.
    PubMed     Text format     Abstract available


  155. KERKHOF M, Ganeff I, Wiggenraad RGJ, Lycklama A Nijeholt GJ, et al
    Clinical applicability of and changes in perfusion MR imaging in brain metastases after stereotactic radiotherapy.
    J Neurooncol. 2018 Feb 1. pii: 10.1007/s11060-018-2779.
    PubMed     Text format     Abstract available


    January 2018
  156. BRONNIMANN C, Izquierdo C, Cartalat S, Thomas L, et al
    Rechallenge with bevacizumab in patients with glioblastoma progressing off therapy.
    J Neurooncol. 2018 Jan 31. pii: 10.1007/s11060-018-2780.
    PubMed     Text format     Abstract available


  157. CHEN M, Zheng SH, Yang M, Chen ZH, et al
    The diagnostic value of preoperative inflammatory markers in craniopharyngioma: a multicenter cohort study.
    J Neurooncol. 2018 Jan 31. pii: 10.1007/s11060-018-2776.
    PubMed     Text format     Abstract available


  158. ALTUNDAG K
    Is there a role of breast pathologist in diagnostic challenges of discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis?
    J Neurooncol. 2018 Jan 31. pii: 10.1007/s11060-018-2778.
    PubMed     Text format    


  159. QIN L, Li A, Qu J, Reinshagen K, et al
    Normalization of ADC does not improve correlation with overall survival in patients with high-grade glioma (HGG).
    J Neurooncol. 2018 Jan 30. pii: 10.1007/s11060-017-2719.
    PubMed     Text format     Abstract available


  160. LOHKAMP LN, Vajkoczy P, Budach V, Kufeld M, et al
    Efficacy, safety and outcome of frameless image-guided robotic radiosurgery for brain metastases after whole brain radiotherapy.
    J Neurooncol. 2018 Jan 29. pii: 10.1007/s11060-018-2771.
    PubMed     Text format     Abstract available


  161. SADASHIVA N, Poyuran R, Mahadevan A, Bhat DI, et al
    Chordoid meningioma: a clinico-pathological study of an uncommon variant of meningioma.
    J Neurooncol. 2018 Jan 27. pii: 10.1007/s11060-018-2748.
    PubMed     Text format     Abstract available


  162. THIBOUW D, Truc G, Bertaut A, Chevalier C, et al
    Clinical and dosimetric study of radiotherapy for glioblastoma: three-dimensional conformal radiotherapy versus intensity-modulated radiotherapy.
    J Neurooncol. 2018 Jan 27. pii: 10.1007/s11060-017-2735.
    PubMed     Text format     Abstract available


  163. HUANG J, Campian JL, Gujar AD, Tsien C, et al
    Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastoma.
    J Neurooncol. 2018 Jan 27. pii: 10.1007/s11060-018-2775.
    PubMed     Text format     Abstract available


  164. MROWCZYNSKI OD, Bourcier AJ, Liao J, Langan ST, et al
    The predictive potential of hyponatremia for glioblastoma patient survival.
    J Neurooncol. 2018 Jan 25. pii: 10.1007/s11060-018-2774.
    PubMed     Text format     Abstract available


  165. LIU YC, Lee IC, Chen PY
    Biomimetic brain tumor niche regulates glioblastoma cells towards a cancer stem cell phenotype.
    J Neurooncol. 2018 Jan 22. pii: 10.1007/s11060-018-2763.
    PubMed     Text format     Abstract available


  166. DONG J, Saunders D, Silasi-Mansat R, Yu L, et al
    Therapeutic efficacy of a synthetic epsin mimetic peptide in glioma tumor model: uncovering multiple mechanisms beyond the VEGF-associated tumor angiogenesis.
    J Neurooncol. 2018 Jan 22. pii: 10.1007/s11060-018-2766.
    PubMed     Text format     Abstract available


  167. ROUX A, Zanello M, Pallud J
    Letter to the editor: local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit.
    J Neurooncol. 2018 Jan 20. pii: 10.1007/s11060-018-2770.
    PubMed     Text format    


  168. KO CC, Lim SW, Chen TY, Chen JH, et al
    Prediction of progression in skull base meningiomas: additional benefits of apparent diffusion coefficient value.
    J Neurooncol. 2018 Jan 20. pii: 10.1007/s11060-018-2769.
    PubMed     Text format     Abstract available


  169. FREEMAN AC, Platt SR, Holmes S, Kent M, et al
    Convection-enhanced delivery of cetuximab conjugated iron-oxide nanoparticles for treatment of spontaneous canine intracranial gliomas.
    J Neurooncol. 2018 Jan 19. pii: 10.1007/s11060-018-2764.
    PubMed     Text format     Abstract available


  170. SEO GH, Choi JH, Kim YM, Koh KN, et al
    Long-term endocrine effects and trends in body mass index changes in patients with childhood-onset brain tumors.
    J Neurooncol. 2018 Jan 19. pii: 10.1007/s11060-018-2765.
    PubMed     Text format     Abstract available


  171. RICK J, Chandra A, Aghi MK
    Tumor treating fields: a new approach to glioblastoma therapy.
    J Neurooncol. 2018 Jan 18. pii: 10.1007/s11060-018-2768.
    PubMed     Text format     Abstract available


  172. DUBINSKI D, Won SY, Gessler F, Quick-Weller J, et al
    Dexamethasone-induced leukocytosis is associated with poor survival in newly diagnosed glioblastoma.
    J Neurooncol. 2018 Jan 18. pii: 10.1007/s11060-018-2761.
    PubMed     Text format     Abstract available


  173. WAN MJ, Zapotocky M, Bouffet E, Bartels U, et al
    Long-term visual outcomes of craniopharyngioma in children.
    J Neurooncol. 2018 Jan 17. pii: 10.1007/s11060-018-2762.
    PubMed     Text format     Abstract available


  174. YUAN Y, Jiaoming L, Xiang W, Yanhui L, et al
    Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma.
    J Neurooncol. 2018 Jan 15. pii: 10.1007/s11060-018-2757.
    PubMed     Text format     Abstract available


  175. MILLER B, Peeri NC, Nabors LB, Creed JH, et al
    Handedness and the risk of glioma.
    J Neurooncol. 2018 Jan 13. pii: 10.1007/s11060-018-2759.
    PubMed     Text format     Abstract available


  176. YOULAND RS, Pafundi DH, Brinkmann DH, Lowe VJ, et al
    Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas.
    J Neurooncol. 2018 Jan 13. pii: 10.1007/s11060-018-2750.
    PubMed     Text format     Abstract available


  177. JAKOBSEN JN, Urup T, Grunnet K, Toft A, et al
    Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients.
    J Neurooncol. 2018 Jan 12. pii: 10.1007/s11060-017-2736.
    PubMed     Text format     Abstract available


  178. DI CRISTOFORI A, Zarino B, Bertani G, Locatelli M, et al
    Surgery in elderly patients with intracranial meningioma: neuropsychological functioning during a long term follow-up.
    J Neurooncol. 2018 Jan 12. pii: 10.1007/s11060-018-2754.
    PubMed     Text format     Abstract available


  179. ARNONE GD, Bhimani AD, Aguilar T, Mehta AI, et al
    Localized targeted antiangiogenic drug delivery for glioblastoma.
    J Neurooncol. 2018 Jan 11. pii: 10.1007/s11060-018-2747.
    PubMed     Text format     Abstract available


  180. BUNEVICIUS A
    Personality traits, patient-centered health status and prognosis of brain tumor patients.
    J Neurooncol. 2018 Jan 11. pii: 10.1007/s11060-018-2751.
    PubMed     Text format     Abstract available


  181. ROH TH, Choi MS, You N, Jeong D, et al
    Identifying candidates for gamma knife radiosurgery among elderly patients with brain metastases.
    J Neurooncol. 2018 Jan 11. pii: 10.1007/s11060-018-2745.
    PubMed     Text format     Abstract available


  182. VAN DER LINDEN SD, Sitskoorn MM, Rutten GM, Gehring K, et al
    Feasibility of the evidence-based cognitive telerehabilitation program Remind for patients with primary brain tumors.
    J Neurooncol. 2018 Jan 10. pii: 10.1007/s11060-017-2738.
    PubMed     Text format     Abstract available


  183. PLANT AS, Koyama S, Sinai C, Solomon IH, et al
    Immunophenotyping of pediatric brain tumors: correlating immune infiltrate with histology, mutational load, and survival and assessing clonal T cell response.
    J Neurooncol. 2018 Jan 10. pii: 10.1007/s11060-017-2737.
    PubMed     Text format     Abstract available


  184. SHI W, Blomain ES, Siglin J, Palmer JD, et al
    Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment.
    J Neurooncol. 2018 Jan 8. pii: 10.1007/s11060-018-2744.
    PubMed     Text format     Abstract available


  185. MICHAELSEN SR, Urup T, Olsen LR, Broholm H, et al
    Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival.
    J Neurooncol. 2018 Jan 5. pii: 10.1007/s11060-017-2739.
    PubMed     Text format     Abstract available


  186. TALARI NK, Panigrahi MK, Madigubba S, Phanithi PB, et al
    Overexpression of aryl hydrocarbon receptor (AHR) signalling pathway in human meningioma.
    J Neurooncol. 2018 Jan 4. pii: 10.1007/s11060-017-2730.
    PubMed     Text format     Abstract available


  187. RAHMAN M, Kresak J, Yang C, Huang J, et al
    Analysis of immunobiologic markers in primary and recurrent glioblastoma.
    J Neurooncol. 2018 Jan 4. pii: 10.1007/s11060-017-2732.
    PubMed     Text format     Abstract available


  188. WANN A, Tully PA, Barnes EH, Lwin Z, et al
    Outcomes after second surgery for recurrent glioblastoma: a retrospective case-control study.
    J Neurooncol. 2018 Jan 2. pii: 10.1007/s11060-017-2731.
    PubMed     Text format     Abstract available


  189. WANG K, Ha T, Chen X, Li S, et al
    A combined diffusion tensor imaging and Ki-67 labeling index study for evaluating the extent of tumor infiltration using the F98 rat glioma model.
    J Neurooncol. 2018 Jan 2. pii: 10.1007/s11060-017-2734.
    PubMed     Text format     Abstract available


  190. MANSUR A, Desimone A, Vaughan S, Schweizer TA, et al
    To drive or not to drive, that is still the question: current challenges in driving recommendations for patients with brain tumours.
    J Neurooncol. 2018 Jan 2. pii: 10.1007/s11060-017-2727.
    PubMed     Text format     Abstract available


  191. PAN YB, Zhang CH, Wang SQ, Ai PH, et al
    Transforming growth factor beta induced (TGFBI) is a potential signature gene for mesenchymal subtype high-grade glioma.
    J Neurooncol. 2018 Jan 2. pii: 10.1007/s11060-017-2729.
    PubMed     Text format     Abstract available


    December 2017
  192. CAPELLADES J, Puig J, Domenech S, Pujol T, et al
    Is a pretreatment radiological staging system feasible for suggesting the optimal extent of resection and predicting prognosis in glioblastoma? An observational study.
    J Neurooncol. 2017 Dec 28. pii: 10.1007/s11060-017-2726.
    PubMed     Text format     Abstract available


  193. LAN YL, Wang X, Lou JC, Ma BB, et al
    Update on the effect of exogenous hormone use on glioma risk in women: a meta-analysis of case-control and cohort studies.
    J Neurooncol. 2017 Dec 26. pii: 10.1007/s11060-017-2725.
    PubMed     Text format     Abstract available


  194. ATTAL J, Chaltiel L, Lubrano V, Sol JC, et al
    Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation.
    J Neurooncol. 2017 Dec 22. pii: 10.1007/s11060-017-2669.
    PubMed     Text format     Abstract available


  195. GOES P, Santos BFO, Suzuki FS, Salles D, et al
    Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
    J Neurooncol. 2017 Dec 21. pii: 10.1007/s11060-017-2721.
    PubMed     Text format     Abstract available


  196. PETERS KB, Lipp ES, Miller E, Herndon JE 2nd, et al
    Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas.
    J Neurooncol. 2017 Dec 21. pii: 10.1007/s11060-017-2724.
    PubMed     Text format     Abstract available


  197. SMITH DR, Wu CC, Saadatmand HJ, Isaacson SR, et al
    Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.
    J Neurooncol. 2017 Dec 20. pii: 10.1007/s11060-017-2718.
    PubMed     Text format     Abstract available


  198. O'REGAN CJ, Kearney H, Beausang A, Farrell MA, et al
    Temporal stability of MGMT promoter methylation in glioblastoma patients undergoing STUPP protocol.
    J Neurooncol. 2017 Dec 20. pii: 10.1007/s11060-017-2722.
    PubMed     Text format     Abstract available


  199. JUNG J, Lee SH, Park M, Youn JH, et al
    Discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis.
    J Neurooncol. 2017 Dec 19. pii: 10.1007/s11060-017-2717.
    PubMed     Text format     Abstract available


  200. XU W, Wang D, Zheng X, Ou Q, et al
    Sex-dependent association of preoperative hematologic markers with glioma grade and progression.
    J Neurooncol. 2017 Dec 19. pii: 10.1007/s11060-017-2714.
    PubMed     Text format     Abstract available


  201. DE ROJAS T, Bautista F, Flores M, Igual L, et al
    Management and outcome of children and adolescents with non-medulloblastoma CNS embryonal tumors in Spain: room for improvement in standards of care.
    J Neurooncol. 2017 Dec 16. pii: 10.1007/s11060-017-2713.
    PubMed     Text format     Abstract available


  202. BROKINKEL B, Stummer W, Sporns P
    Simpson grade IV resections of skull base meningiomas: does the postoperative tumor volume impact progression?
    J Neurooncol. 2017 Dec 14. pii: 10.1007/s11060-017-2715.
    PubMed     Text format    


  203. BOELE FW, Klein M, Verdonck-de Leeuw IM, Cuijpers P, et al
    Internet-based guided self-help for glioma patients with depressive symptoms: a randomized controlled trial.
    J Neurooncol. 2017 Dec 13. pii: 10.1007/s11060-017-2712.
    PubMed     Text format     Abstract available


  204. SHI W, Blomain ES, Siglin J, Palmer JJ, et al
    Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment.
    J Neurooncol. 2017 Dec 12. pii: 10.1007/s11060-017-2709.
    PubMed     Text format     Abstract available


  205. ROGERS TW, Toor G, Drummond K, Love C, et al
    The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas.
    J Neurooncol. 2017 Dec 7. pii: 10.1007/s11060-017-2710.
    PubMed     Text format     Abstract available


  206. PRABHU RS, Press RH, Boselli DM, Miller KR, et al
    External validity of two nomograms for predicting distant brain failure after radiosurgery for brain metastases in a bi-institutional independent patient cohort.
    J Neurooncol. 2017 Dec 7. pii: 10.1007/s11060-017-2707.
    PubMed     Text format     Abstract available


  207. VENTURA LM, Grieco JA, Evans CL, Kuhlthau KA, et al
    Executive functioning, academic skills, and quality of life in pediatric patients with brain tumors post-proton radiation therapy.
    J Neurooncol. 2017 Dec 6. pii: 10.1007/s11060-017-2703.
    PubMed     Text format     Abstract available


  208. LAKOMKIN N, Hadjipanayis CG
    Non-routine discharge disposition is associated with post-discharge complications and 30-day readmissions following craniotomy for brain tumor resection.
    J Neurooncol. 2017 Dec 5. pii: 10.1007/s11060-017-2689.
    PubMed     Text format     Abstract available


  209. BINGHAM B, Patel CG, Shinohara ET, Attia A, et al
    Utilization of hypofractionated radiotherapy in treatment of glioblastoma multiforme in elderly patients not receiving adjuvant chemoradiotherapy: A National Cancer Database Analysis.
    J Neurooncol. 2017 Dec 5. pii: 10.1007/s11060-017-2665.
    PubMed     Text format     Abstract available


  210. KLINE C, Felton E, Allen IE, Tahir P, et al
    Survival outcomes in pediatric recurrent high-grade glioma: results of a 20-year systematic review and meta-analysis.
    J Neurooncol. 2017 Dec 4. pii: 10.1007/s11060-017-2701.
    PubMed     Text format     Abstract available


  211. QIAN Z, Li Y, Fan X, Zhang C, et al
    Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas.
    J Neurooncol. 2017 Dec 4. pii: 10.1007/s11060-017-2704.
    PubMed     Text format     Abstract available


  212. LOBON-IGLESIAS MJ, Giraud G, Castel D, Philippe C, et al
    Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients?
    J Neurooncol. 2017 Dec 2. pii: 10.1007/s11060-017-2702.
    PubMed     Text format     Abstract available


  213. FANG P, Boehling NS, Koay EJ, Bucheit AD, et al
    Melanoma brain metastases harboring BRAF (V600K) or NRAS mutations are associated with an increased local failure rate following conventional therapy.
    J Neurooncol. 2017 Dec 2. pii: 10.1007/s11060-017-2695.
    PubMed     Text format     Abstract available


  214. PICART T, Barritault M, Berthillier J, Meyronet D, et al
    Characteristics of cerebellar glioblastomas in adults.
    J Neurooncol. 2017 Dec 1. pii: 10.1007/s11060-017-2682.
    PubMed     Text format     Abstract available


  215. GOETHE E, Carter BZ, Rao G, Pemmaraju N, et al
    Glioblastoma and acute myeloid leukemia: malignancies with striking similarities.
    J Neurooncol. 2017 Dec 1. pii: 10.1007/s11060-017-2676.
    PubMed     Text format     Abstract available


  216. ANTONSSON M, Longoni F, Jakola A, Tisell M, et al
    Pre-operative language ability in patients with presumed low-grade glioma.
    J Neurooncol. 2017 Dec 1. pii: 10.1007/s11060-017-2699.
    PubMed     Text format     Abstract available


    November 2017
  217. CURET MA, Watters JJ
    P2Y14 receptor activation decreases interleukin-6 production and glioma GL261 cell proliferation in microglial transwell cultures.
    J Neurooncol. 2017 Nov 30. pii: 10.1007/s11060-017-2700.
    PubMed     Text format     Abstract available


  218. TAMURA R, Ohara K, Sasaki H, Morimoto Y, et al
    Histopathological vascular investigation of the peritumoral brain zone of glioblastomas.
    J Neurooncol. 2017 Nov 29. pii: 10.1007/s11060-017-2648.
    PubMed     Text format     Abstract available


  219. CARDONA AF, Rojas L, Wills B, Bernal L, et al
    Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma.
    J Neurooncol. 2017 Nov 25. pii: 10.1007/s11060-017-2660.
    PubMed     Text format     Abstract available


  220. WANG W, Zhao Z, Yang F, Wang H, et al
    An immune-related lncRNA signature for patients with anaplastic gliomas.
    J Neurooncol. 2017 Nov 23. pii: 10.1007/s11060-017-2667.
    PubMed     Text format     Abstract available


  221. YANG L, Chen CJ, Guo XL, Wu XC, et al
    Bevacizumab and risk of intracranial hemorrhage in patients with brain metastases: a meta-analysis.
    J Neurooncol. 2017 Nov 23. pii: 10.1007/s11060-017-2693.
    PubMed     Text format     Abstract available


  222. WANG W, Zhao Z, Wu F, Wang H, et al
    Bioinformatic analysis of gene expression and methylation regulation in glioblastoma.
    J Neurooncol. 2017 Nov 22. doi: 10.1007/s11060-017-2688.
    PubMed     Text format     Abstract available


  223. HAN J, Puri RK
    Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor alpha1 and alpha2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
    J Neurooncol. 2017 Nov 22. doi: 10.1007/s11060-017-2680.
    PubMed     Text format     Abstract available


  224. CORREA DD, Kryza-Lacombe M, Zhou X, Baser RE, et al
    A pilot study of neuropsychological functions, APOE and amyloid imaging in patients with gliomas.
    J Neurooncol. 2017 Nov 22. doi: 10.1007/s11060-017-2692.
    PubMed     Text format     Abstract available


  225. MA R, Levy M, Gui B, Lu SE, et al
    Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery.
    J Neurooncol. 2017 Nov 20. doi: 10.1007/s11060-017-2666.
    PubMed     Text format     Abstract available


  226. AUDUREAU E, Chivet A, Ursu R, Corns R, et al
    Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model.
    J Neurooncol. 2017 Nov 20. doi: 10.1007/s11060-017-2685.
    PubMed     Text format     Abstract available


  227. FACCHINI G, Ignarro RS, Rodrigues-Silva E, Vieira AS, et al
    Toxic effects of phytol and retinol on human glioblastoma cells are associated with modulation of cholesterol and fatty acid biosynthetic pathways.
    J Neurooncol. 2017 Nov 20. doi: 10.1007/s11060-017-2672.
    PubMed     Text format     Abstract available


  228. XU G, Li JY
    CK4, CK6, cyclin D1, p16(INK4a) and EGFR expression in glioblastoma with a primitive neuronal component.
    J Neurooncol. 2017 Nov 17. doi: 10.1007/s11060-017-2674.
    PubMed     Text format     Abstract available


  229. SCHIPMANN S, Molina ES, Frasch A, Stummer W, et al
    Initial psycho-oncological counselling in neuro-oncology: analysis of topics and needs of brain tumour patients.
    J Neurooncol. 2017 Nov 17. doi: 10.1007/s11060-017-2670.
    PubMed     Text format     Abstract available


  230. TONSE R, Gupta T, Epari S, Shastri JG, et al
    Impact of WHO 2016 update of brain tumor classification, molecular markers and clinical outcomes in pleomorphic xanthoastrocytoma.
    J Neurooncol. 2017 Nov 16. doi: 10.1007/s11060-017-2658.
    PubMed     Text format     Abstract available


  231. LEE KS, Lee K, Yun S, Moon S, et al
    Prognostic relevance of programmed cell death ligand 1 expression in glioblastoma.
    J Neurooncol. 2017 Nov 16. doi: 10.1007/s11060-017-2675.
    PubMed     Text format     Abstract available


  232. LIN AJ, Campian JL, Hui C, Rudra S, et al
    Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapy.
    J Neurooncol. 2017 Nov 16. doi: 10.1007/s11060-017-2668.
    PubMed     Text format     Abstract available


  233. PATEL S, Wang S, Snuderl M, Karajannis MA, et al
    Pre-treatment lymphopenia and indication of tumor-induced systemic immunosuppression in medulloblastoma.
    J Neurooncol. 2017 Nov 16. doi: 10.1007/s11060-017-2678.
    PubMed     Text format     Abstract available


  234. ALBATANY M, Li A, Meakin S, Bartha R, et al
    Dichloroacetate induced intracellular acidification in glioblastoma: in vivo detection using AACID-CEST MRI at 9.4 Tesla.
    J Neurooncol. 2017 Nov 16. doi: 10.1007/s11060-017-2664.
    PubMed     Text format     Abstract available


  235. NAGASHIMA H, Sasayama T, Tanaka K, Kyotani K, et al
    Myo-inositol concentration in MR spectroscopy for differentiating high grade glioma from primary central nervous system lymphoma.
    J Neurooncol. 2017 Nov 15. doi: 10.1007/s11060-017-2655.
    PubMed     Text format     Abstract available


  236. IZQUIERDO C, Alentorn A, Idbaih A, Simo M, et al
    Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics.
    J Neurooncol. 2017 Nov 15. doi: 10.1007/s11060-017-2677.
    PubMed     Text format     Abstract available


  237. YUSUF MB, Amsbaugh MJ, Burton E, Nelson M, et al
    Increasing time to postoperative stereotactic radiation therapy for patients with resected brain metastases: investigating clinical outcomes and identifying predictors associated with time to initiation.
    J Neurooncol. 2017 Nov 15. doi: 10.1007/s11060-017-2679.
    PubMed     Text format     Abstract available


  238. TAO X, Wang K, Dong J, Hou Z, et al
    Clinical features, surgical management, and prognostic factors of secretory meningiomas: a single-center case series of 149 patients.
    J Neurooncol. 2017 Nov 15. doi: 10.1007/s11060-017-2671.
    PubMed     Text format     Abstract available


  239. LAM SHIN CHEUNG V, Kim A, Sahgal A, Das S, et al
    Meningioma recurrence rates following treatment: a systematic analysis.
    J Neurooncol. 2017 Nov 15. doi: 10.1007/s11060-017-2659.
    PubMed     Text format     Abstract available


  240. FRIED I, Lossos A, Ben Ami T, Dvir R, et al
    Preliminary results of immune modulating antibody MDV9300 (pidilizumab) treatment in children with diffuse intrinsic pontine glioma.
    J Neurooncol. 2017 Nov 15. doi: 10.1007/s11060-017-2643.
    PubMed     Text format     Abstract available


  241. SAGE W, Guilfoyle M, Luney C, Young A, et al
    Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit.
    J Neurooncol. 2017 Nov 14. doi: 10.1007/s11060-017-2649.
    PubMed     Text format     Abstract available


  242. FRANCESCHI E, Depenni R, Paccapelo A, Ermani M, et al
    Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study.
    J Neurooncol. 2017 Nov 9. doi: 10.1007/s11060-017-2638.
    PubMed     Text format     Abstract available


  243. LAVRADOR JP, Pinto MV, Lemos LM, Ribeiro C, et al
    Meningioma and breast cancer: survival of patients with synchronous and metachronous meningioma and breast cancer.
    J Neurooncol. 2017 Nov 8. doi: 10.1007/s11060-017-2640.
    PubMed     Text format     Abstract available


  244. KHAN RB, Merchant TE, Sadighi ZS, Bello MS, et al
    Prevalence, risk factors, and response to treatment for hypersomnia of central origin in survivors of childhood brain tumors.
    J Neurooncol. 2017 Nov 8. doi: 10.1007/s11060-017-2662.
    PubMed     Text format     Abstract available


  245. LIN M, Zhang X, Jia B, Guan S, et al
    Suppression of glioblastoma growth and angiogenesis through molecular targeting of methionine aminopeptidase-2.
    J Neurooncol. 2017 Nov 8. doi: 10.1007/s11060-017-2663.
    PubMed     Text format     Abstract available


  246. JOHNSON DR, Hunt CH, Nathan MA, Parisi JE, et al
    Pittsburgh compound B (PiB) PET imaging of meningioma and other intracranial tumors.
    J Neurooncol. 2017 Nov 8. doi: 10.1007/s11060-017-2661.
    PubMed     Text format     Abstract available


  247. LOUREIRO LVM, Malheiros SMF
    Early initiation of chemoradiation may not influence survival of high-grade gliomas.
    J Neurooncol. 2017 Nov 8. doi: 10.1007/s11060-017-2633.
    PubMed     Text format    


  248. MCCULLOUGH BJ, Ader V, Aguedan B, Feng X, et al
    Preoperative relative cerebral blood volume analysis in gliomas predicts survival and mitigates risk of biopsy sampling error.
    J Neurooncol. 2017 Nov 2. doi: 10.1007/s11060-017-2642.
    PubMed     Text format     Abstract available


  249. FUJIMOTO D, von Eyben R, Gibbs IC, Chang SD, et al
    Imaging changes over 18 months following stereotactic radiosurgery for brain metastases: both late radiation necrosis and tumor progression can occur.
    J Neurooncol. 2017 Nov 2. doi: 10.1007/s11060-017-2647.
    PubMed     Text format     Abstract available


    October 2017
  250. HAQUE W, Verma V, Butler EB, Teh BS, et al
    Addition of chemotherapy to hypofractionated radiotherapy for glioblastoma: practice patterns, outcomes, and predictors of survival.
    J Neurooncol. 2017 Oct 31. doi: 10.1007/s11060-017-2654.
    PubMed     Text format     Abstract available


  251. ALTUNDAG K
    Prognostic effect of neutrophil-lymphocyte ratio during concurrrent chemo-radiotherapy period in glioblastoma patients who did not receive dexamethasone.
    J Neurooncol. 2017 Oct 31. doi: 10.1007/s11060-017-2645.
    PubMed     Text format    


  252. PROTOPAPA M, Zygogianni A, Stamatakos GS, Antypas C, et al
    Clinical implications of in silico mathematical modeling for glioblastoma: a critical review.
    J Neurooncol. 2017 Oct 28. doi: 10.1007/s11060-017-2650.
    PubMed     Text format     Abstract available


  253. MASALHA W, Heiland DH, Franco P, Delev D, et al
    Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy.
    J Neurooncol. 2017 Oct 28. doi: 10.1007/s11060-017-2634.
    PubMed     Text format     Abstract available


  254. HARLAND TA, Freeman JL, Davern M, McCracken DJ, et al
    Progesterone-only contraception is associated with a shorter progression-free survival in premenopausal women with WHO Grade I meningioma.
    J Neurooncol. 2017 Oct 28. doi: 10.1007/s11060-017-2656.
    PubMed     Text format     Abstract available


  255. LI W, Liu Y, Yang W, Han X, et al
    MicroRNA-378 enhances radiation response in ectopic and orthotopic implantation models of glioblastoma.
    J Neurooncol. 2017 Oct 28. doi: 10.1007/s11060-017-2646.
    PubMed     Text format     Abstract available


  256. DENG S, Li Y, Yi G, Lei B, et al
    Overexpression of COX7A2 is associated with a good prognosis in patients with glioma.
    J Neurooncol. 2017 Oct 27. doi: 10.1007/s11060-017-2637.
    PubMed     Text format     Abstract available


  257. GATELY L, McLachlan SA, Philip J, Ruben J, et al
    Long-term survivors of glioblastoma: a closer look.
    J Neurooncol. 2017 Oct 27. doi: 10.1007/s11060-017-2635.
    PubMed     Text format     Abstract available


  258. LOPES M, Carvalho B, Vaz R, Linhares P, et al
    Influence of neutrophil-lymphocyte ratio in prognosis of glioblastoma multiforme.
    J Neurooncol. 2017 Oct 26. doi: 10.1007/s11060-017-2641.
    PubMed     Text format     Abstract available


  259. SANTANGELO A, Imbruce P, Gardenghi B, Belli L, et al
    A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker.
    J Neurooncol. 2017 Oct 26. doi: 10.1007/s11060-017-2639.
    PubMed     Text format     Abstract available


  260. AZIZI AA, Schouten-van Meeteren AYN
    Current and emerging treatment strategies for children with progressive chiasmatic-hypothalamic glioma diagnosed as infants: a web-based survey.
    J Neurooncol. 2017 Oct 25. doi: 10.1007/s11060-017-2630.
    PubMed     Text format     Abstract available


  261. VAN ZANTEN SEMV, El-Khouly FE, Jansen MHA, Bakker DP, et al
    Correction to: A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma.
    J Neurooncol. 2017 Oct 23. doi: 10.1007/s11060-017-2636.
    PubMed     Text format     Abstract available


  262. MIYAI M, Tomita H, Soeda A, Yano H, et al
    Current trends in mouse models of glioblastoma.
    J Neurooncol. 2017 Oct 20. doi: 10.1007/s11060-017-2626.
    PubMed     Text format     Abstract available


  263. SENDERS JT, Goldhaber NH, Cote DJ, Muskens IS, et al
    Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis.
    J Neurooncol. 2017 Oct 16. doi: 10.1007/s11060-017-2631.
    PubMed     Text format     Abstract available


  264. RUDA R, Pellerino A, Franchino F, Bertolotti C, et al
    Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study.
    J Neurooncol. 2017 Oct 13. doi: 10.1007/s11060-017-2628.
    PubMed     Text format     Abstract available


  265. DE B, Beal K, De Braganca KC, Souweidane MM, et al
    Long-term outcomes of adult medulloblastoma patients treated with radiotherapy.
    J Neurooncol. 2017 Oct 10. doi: 10.1007/s11060-017-2627.
    PubMed     Text format     Abstract available


  266. LUKAS RV, Lesniak MS, Stupp R
    Hospital volume and group expertise in newly diagnosed glioblastoma management.
    J Neurooncol. 2017 Oct 7. doi: 10.1007/s11060-017-2632.
    PubMed     Text format    


  267. NGHIEMPHU PL, Ebiana VA, Wen P, Gilbert M, et al
    Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02.
    J Neurooncol. 2017 Oct 7. doi: 10.1007/s11060-017-2624.
    PubMed     Text format     Abstract available


  268. DONOHO DA, Wen T, Babadjouni RM, Schwartzman W, et al
    Predictors of 30- and 90-day readmission following craniotomy for malignant brain tumors: analysis of nationwide data.
    J Neurooncol. 2017 Oct 7. doi: 10.1007/s11060-017-2625.
    PubMed     Text format     Abstract available


  269. DUERINCK J, Du Four S, Bouttens F, Andre C, et al
    Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma.
    J Neurooncol. 2017 Oct 7. doi: 10.1007/s11060-017-2629.
    PubMed     Text format     Abstract available


  270. ARVOLD ND, Shi DD, Aizer AA, Norden AD, et al
    Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.
    J Neurooncol. 2017 Oct 3. doi: 10.1007/s11060-017-2611.
    PubMed     Text format     Abstract available


    September 2017
  271. JACOBS DI, Liu Y, Gabrusiewicz K, Tsavachidis S, et al
    Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients.
    J Neurooncol. 2017 Sep 30. doi: 10.1007/s11060-017-2622.
    PubMed     Text format     Abstract available


  272. KELLY C, Majewska P, Ioannidis S, Raza MH, et al
    Estimating progression-free survival in patients with glioblastoma using routinely collected data.
    J Neurooncol. 2017 Sep 27. doi: 10.1007/s11060-017-2619.
    PubMed     Text format     Abstract available


  273. ZHANG G, Zhang Y, Cheng S, Wu Z, et al
    CD133 positive U87 glioblastoma cells-derived exosomal microRNAs in hypoxia- versus normoxia-microenviroment.
    J Neurooncol. 2017 Sep 25. doi: 10.1007/s11060-017-2566.
    PubMed     Text format     Abstract available


  274. HARYU S, Saito R, Jia W, Shoji T, et al
    Convection-enhanced delivery of sulfasalazine prolongs survival in a glioma stem cell brain tumor model.
    J Neurooncol. 2017 Sep 19. doi: 10.1007/s11060-017-2621.
    PubMed     Text format     Abstract available


  275. DELFANTI RL, Piccioni DE, Handwerker J, Bahrami N, et al
    Erratum to: Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status.
    J Neurooncol. 2017 Sep 13. doi: 10.1007/s11060-017-2620.
    PubMed     Text format     Abstract available


  276. PRAH MA, Al-Gizawiy MM, Mueller WM, Cochran EJ, et al
    Spatial discrimination of glioblastoma and treatment effect with histologically-validated perfusion and diffusion magnetic resonance imaging metrics.
    J Neurooncol. 2017 Sep 12. doi: 10.1007/s11060-017-2617.
    PubMed     Text format     Abstract available


  277. LI Y, Qian Z, Xu K, Wang K, et al
    Radiomic features predict Ki-67 expression level and survival in lower grade gliomas.
    J Neurooncol. 2017 Sep 12. doi: 10.1007/s11060-017-2576.
    PubMed     Text format     Abstract available


  278. ALTUNDAG K
    Her2 positive subtype and breast cancer brain metastasis: any effect of anti-Her2 targeted therapy?
    J Neurooncol. 2017 Sep 12. doi: 10.1007/s11060-017-2623.
    PubMed     Text format    


  279. LIU X, Mangla R, Tian W, Qiu X, et al
    The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma.
    J Neurooncol. 2017 Sep 9. doi: 10.1007/s11060-017-2602.
    PubMed     Text format     Abstract available


  280. LIU C, Wu H, Li Y, Shen L, et al
    SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway.
    J Neurooncol. 2017 Sep 8. doi: 10.1007/s11060-017-2589.
    PubMed     Text format     Abstract available


  281. ETXANIZ O, Carrato C, de Aguirre I, Queralt C, et al
    IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas.
    J Neurooncol. 2017 Sep 7. doi: 10.1007/s11060-017-2570.
    PubMed     Text format     Abstract available


  282. JOSHI S, Cooke JRN, Ellis JA, Emala CW, et al
    Targeting brain tumors by intra-arterial delivery of cell-penetrating peptides: a novel approach for primary and metastatic brain malignancy.
    J Neurooncol. 2017 Sep 5. doi: 10.1007/s11060-017-2615.
    PubMed     Text format     Abstract available


  283. ARUN S, Ravisankar S, Vanisree AJ
    Implication of connexin30 on the stemness of glioma: connexin30 reverses the malignant phenotype of glioma by modulating IGF-1R, CD133 and cMyc.
    J Neurooncol. 2017 Sep 5. doi: 10.1007/s11060-017-2608.
    PubMed     Text format     Abstract available


  284. DELFANTI RL, Piccioni DE, Handwerker J, Bahrami N, et al
    Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status.
    J Neurooncol. 2017 Sep 4. doi: 10.1007/s11060-017-2613.
    PubMed     Text format     Abstract available


  285. JIAO JT, Sun J, Ma JF, Dai MC, et al
    Retraction Note to: Relationship between inflammatory cytokines and risk of depression, and effect of depression on the prognosis of high grade glioma patients.
    J Neurooncol. 2017;134:475.
    PubMed     Text format    


    August 2017
  286. RASMUSSEN BK, Hansen S, Laursen RJ, Kosteljanetz M, et al
    Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I-IV in the the Danish Neuro-Oncology Registry.
    J Neurooncol. 2017 Aug 31. doi: 10.1007/s11060-017-2607.
    PubMed     Text format     Abstract available


  287. KOSHIYAMA DB, Trevisan P, Graziadio C, Rosa RFM, et al
    Frequency and clinical significance of chromosome 7 and 10 aneuploidies, amplification of the EGFR gene, deletion of PTEN and TP53 genes, and 1p/19q deficiency in a sample of adult patients diagnosed with glioblastoma from Southern Brazil.
    J Neurooncol. 2017 Aug 30. doi: 10.1007/s11060-017-2606.
    PubMed     Text format     Abstract available


  288. LAKOMKIN N, Hadjipanayis CG
    Resident participation is not associated with postoperative adverse events, reoperation, or prolonged length of stay following craniotomy for brain tumor resection.
    J Neurooncol. 2017 Aug 30. doi: 10.1007/s11060-017-2614.
    PubMed     Text format     Abstract available


  289. XU X, Cai N, Bao Z, You Y, et al
    Silencing Pre-B-cell leukemia homeobox 3 decreases the proliferation of human glioma cells in vitro and in vivo.
    J Neurooncol. 2017 Aug 30. doi: 10.1007/s11060-017-2603.
    PubMed     Text format     Abstract available


  290. ROCCOGRANDI L, Binder ZA, Zhang L, Aceto N, et al
    SHP2 regulates proliferation and tumorigenicity of glioma stem cells.
    J Neurooncol. 2017 Aug 29. doi: 10.1007/s11060-017-2610.
    PubMed     Text format     Abstract available


  291. THORSTEINSDOTTIR J, Stangl S, Fu P, Guo K, et al
    Overexpression of cytosolic, plasma membrane bound and extracellular heat shock protein 70 (Hsp70) in primary glioblastomas.
    J Neurooncol. 2017 Aug 28. doi: 10.1007/s11060-017-2600.
    PubMed     Text format     Abstract available


  292. ZHU JJ, Demireva P, Kanner AA, Pannullo S, et al
    Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma.
    J Neurooncol. 2017 Aug 28. doi: 10.1007/s11060-017-2601.
    PubMed     Text format     Abstract available


  293. KOSHY M, Sher DJ, Spiotto M, Husain Z, et al
    Association between hospital volume and receipt of treatment and survival in patients with glioblastoma.
    J Neurooncol. 2017 Aug 23. doi: 10.1007/s11060-017-2598.
    PubMed     Text format     Abstract available


  294. YOULAND RS, Kreofsky CR, Schomas DA, Brown PD, et al
    The impact of adjuvant therapy for patients with high-risk diffuse WHO grade II glioma.
    J Neurooncol. 2017 Aug 23. doi: 10.1007/s11060-017-2599.
    PubMed     Text format     Abstract available


  295. AYALA-PEACOCK DN, Attia A, Braunstein SE, Ahluwalia MS, et al
    Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogram.
    J Neurooncol. 2017 Aug 21. doi: 10.1007/s11060-017-2588.
    PubMed     Text format     Abstract available


  296. KHANNA V, Achey RL, Ostrom QT, Block-Beach H, et al
    Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013.
    J Neurooncol. 2017 Aug 21. doi: 10.1007/s11060-017-2594.
    PubMed     Text format     Abstract available


  297. FORTIN D, Tsang D, Ng A, Laperriere N, et al
    Monte Carlo-driven predictions of neurocognitive and hearing impairments following proton and photon radiotherapy for pediatric brain-tumor patients.
    J Neurooncol. 2017 Aug 19. doi: 10.1007/s11060-017-2597.
    PubMed     Text format     Abstract available


  298. FRINTON E, Tong D, Tan J, Read G, et al
    Metastatic melanoma: prognostic factors and survival in patients with brain metastases.
    J Neurooncol. 2017 Aug 17. doi: 10.1007/s11060-017-2591.
    PubMed     Text format     Abstract available


  299. ZHAO F, Li C, Zhou Q, Qu P, et al
    Distinctive localization and MRI features correlate of molecular subgroups in adult medulloblastoma.
    J Neurooncol. 2017 Aug 14. doi: 10.1007/s11060-017-2581.
    PubMed     Text format     Abstract available


  300. GE M, Zhuang Y, Zhou X, Huang R, et al
    High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases.
    J Neurooncol. 2017 Aug 5. doi: 10.1007/s11060-017-2590.
    PubMed     Text format     Abstract available


  301. WEGENSCHIMMEL B, Leiss U, Veigl M, Rosenmayr V, et al
    Do we still need IQ-scores? Misleading interpretations of neurocognitive outcome in pediatric patients with medulloblastoma: a retrospective study.
    J Neurooncol. 2017 Aug 4. doi: 10.1007/s11060-017-2582.
    PubMed     Text format     Abstract available


    July 2017
  302. GANDHI P, Khare R, Garg N
    Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker?
    J Neurooncol. 2017 Jul 29. doi: 10.1007/s11060-017-2578.
    PubMed     Text format     Abstract available


  303. HENKER C, Kriesen T, Glass A, Schneider B, et al
    Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival.
    J Neurooncol. 2017 Jul 28. doi: 10.1007/s11060-017-2587.
    PubMed     Text format     Abstract available


  304. FOGLI A, Demattei MV, Corset L, Vaurs-Barriere C, et al
    Detection of the alternative lengthening of telomeres pathway in malignant gliomas for improved molecular diagnosis.
    J Neurooncol. 2017 Jul 28. doi: 10.1007/s11060-017-2585.
    PubMed     Text format     Abstract available


  305. GUPTA T, Dasgupta A, Epari S, Shirsat N, et al
    Extraneuraxial metastases in medulloblastoma: is histology and molecular biology important?
    J Neurooncol. 2017 Jul 28. doi: 10.1007/s11060-017-2586.
    PubMed     Text format    


  306. WALI AR, Rennert RC, Wang SG, Chen CC, et al
    Prophylactic anticonvulsants in patients with primary glioblastoma.
    J Neurooncol. 2017 Jul 28. doi: 10.1007/s11060-017-2584.
    PubMed     Text format     Abstract available


  307. LU FF, Wang HY, He XZ, Liang TY, et al
    Prognostic value of ion channel genes in Chinese patients with gliomas based on mRNA expression profiling.
    J Neurooncol. 2017 Jul 27. doi: 10.1007/s11060-017-2539.
    PubMed     Text format     Abstract available


  308. HAYASHI N, Mitsuya K, Nakasu Y, Naito T, et al
    Negative impact of leukoaraiosis on the incidence of brain metastases in patients with lung cancer.
    J Neurooncol. 2017 Jul 27. doi: 10.1007/s11060-017-2574.
    PubMed     Text format     Abstract available


  309. LILJEHULT MM, Buus L, Liljehult J, Rasmussen BK, et al
    Walking ability in patients with glioblastoma: prognostic value of the Berg Balance Scale and the 10 meter walk test.
    J Neurooncol. 2017 Jul 27. doi: 10.1007/s11060-017-2579.
    PubMed     Text format     Abstract available


  310. TSANG DS, Murphy ES, Lucas JT Jr, Lagiou P, et al
    Pseudoprogression in pediatric low-grade glioma after irradiation.
    J Neurooncol. 2017 Jul 27. doi: 10.1007/s11060-017-2583.
    PubMed     Text format     Abstract available


  311. VELDHUIJZEN VAN ZANTEN SEM, El-Khouly FE, Jansen MHA, Bakker DP, et al
    A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma.
    J Neurooncol. 2017 Jul 26. doi: 10.1007/s11060-017-2575.
    PubMed     Text format     Abstract available


  312. VISANI M, Acquaviva G, Marucci G, Paccapelo A, et al
    Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria.
    J Neurooncol. 2017 Jul 26. doi: 10.1007/s11060-017-2571.
    PubMed     Text format     Abstract available


  313. NATHAN JK, Brezzell AL, Kim MM, Leung D, et al
    Early initiation of chemoradiation following index craniotomy is associated with decreased survival in high-grade glioma.
    J Neurooncol. 2017 Jul 25. doi: 10.1007/s11060-017-2577.
    PubMed     Text format     Abstract available


  314. VAN LINDE ME, Brahm CG, de Witt Hamer PC, Reijneveld JC, et al
    Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis.
    J Neurooncol. 2017 Jul 20. doi: 10.1007/s11060-017-2564.
    PubMed     Text format     Abstract available


  315. ZANELLO M, Roux A, Ursu R, Peeters S, et al
    Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?
    J Neurooncol. 2017 Jul 19. doi: 10.1007/s11060-017-2573.
    PubMed     Text format     Abstract available


  316. TIAN J, Luo Y, Xiang J, Tang J, et al
    Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.
    J Neurooncol. 2017 Jul 19. doi: 10.1007/s11060-017-2572.
    PubMed     Text format     Abstract available


  317. ZHANG C, de Smith AJ, Smirnov IV, Wiencke JK, et al
    Non-additive and epistatic effects of HLA polymorphisms contributing to risk of adult glioma.
    J Neurooncol. 2017 Jul 18. doi: 10.1007/s11060-017-2569.
    PubMed     Text format     Abstract available


  318. VIETHEER JM, Rieger J, Wagner M, Senft C, et al
    Serum concentrations of glial fibrillary acidic protein (GFAP) do not indicate tumor recurrence in patients with glioblastoma.
    J Neurooncol. 2017 Jul 17. doi: 10.1007/s11060-017-2565.
    PubMed     Text format     Abstract available


  319. CACHIA D, Elshafeey NA, Kamiya-Matsuoka C, Hatami M, et al
    Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients.
    J Neurooncol. 2017 Jul 12. doi: 10.1007/s11060-017-2550.
    PubMed     Text format     Abstract available


  320. YUST-KATZ S, Inbar E, Michaeli N, Limon D, et al
    Aberrant paramagnetic signals outside the tumor volume on routine surveillance MRI of brain tumor patients.
    J Neurooncol. 2017 Jul 10. doi: 10.1007/s11060-017-2536.
    PubMed     Text format     Abstract available


  321. PESSINA F, Navarria P, Cozzi L, Ascolese AM, et al
    Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.
    J Neurooncol. 2017 Jul 8. doi: 10.1007/s11060-017-2559.
    PubMed     Text format     Abstract available


  322. HAQUE W, Verma V, Butler EB, Teh BS, et al
    Definitive chemoradiation at high volume facilities is associated with improved survival in glioblastoma.
    J Neurooncol. 2017 Jul 7. doi: 10.1007/s11060-017-2563.
    PubMed     Text format     Abstract available


  323. CHRISTODOULOU C, Kalogera-Fountzila A, Karavasilis V, Kouvatseas G, et al
    Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG).
    J Neurooncol. 2017 Jul 7. doi: 10.1007/s11060-017-2548.
    PubMed     Text format     Abstract available


  324. AWAD AW, Karsy M, Sanai N, Spetzler R, et al
    Impact of removed tumor volume and location on patient outcome in glioblastoma.
    J Neurooncol. 2017 Jul 6. doi: 10.1007/s11060-017-2562.
    PubMed     Text format     Abstract available


  325. DI CRISTOFORI A, Zarino B, Fanizzi C, Fornara GA, et al
    Analysis of factors influencing the access to concomitant chemo-radiotherapy in elderly patients with high grade gliomas: role of MMSE, age and tumor volume.
    J Neurooncol. 2017 Jul 6. doi: 10.1007/s11060-017-2537.
    PubMed     Text format     Abstract available


  326. HASSAN H, Pinches A, Picton SV, Phillips RS, et al
    Survival rates and prognostic predictors of high grade brain stem gliomas in childhood: a systematic review and meta-analysis.
    J Neurooncol. 2017 Jul 5. doi: 10.1007/s11060-017-2546.
    PubMed     Text format     Abstract available


  327. CHANG E, Pohling C, Beygui N, Patel CB, et al
    Synergistic inhibition of glioma cell proliferation by Withaferin A and tumor treating fields.
    J Neurooncol. 2017 Jul 5. doi: 10.1007/s11060-017-2534.
    PubMed     Text format     Abstract available


  328. ROSAGER AM, Sorensen MD, Dahlrot RH, Boldt HB, et al
    Expression and prognostic value of JAM-A in gliomas.
    J Neurooncol. 2017 Jul 4. doi: 10.1007/s11060-017-2555.
    PubMed     Text format     Abstract available


  329. PARK M, Lee SK, Chang JH, Kang SG, et al
    Elderly patients with newly diagnosed glioblastoma: can preoperative imaging descriptors improve the predictive power of a survival model?
    J Neurooncol. 2017 Jul 3. doi: 10.1007/s11060-017-2544.
    PubMed     Text format     Abstract available


  330. DETSKY JS, Keith J, Conklin J, Symons S, et al
    Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology.
    J Neurooncol. 2017 Jul 3. doi: 10.1007/s11060-017-2545.
    PubMed     Text format     Abstract available


  331. SARAF A, Grubb CS, Hwang ME, Tai CH, et al
    Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development.
    J Neurooncol. 2017 Jul 3. doi: 10.1007/s11060-017-2549.
    PubMed     Text format     Abstract available


  332. KAPADIA A, Mehrabian H, Conklin J, Symons SP, et al
    Temporal evolution of perfusion parameters in brain metastases treated with stereotactic radiosurgery: comparison of intravoxel incoherent motion and dynamic contrast enhanced MRI.
    J Neurooncol. 2017 Jul 1. doi: 10.1007/s11060-017-2556.
    PubMed     Text format     Abstract available


  333. YU A, Faiq N, Green S, Lai A, et al
    Report of safety of pulse dosing of lapatinib with temozolomide and radiation therapy for newly-diagnosed glioblastoma in a pilot phase II study.
    J Neurooncol. 2017 Jul 1. doi: 10.1007/s11060-017-2533.
    PubMed     Text format     Abstract available


  334. ROUX A, Peeters S, Zanello M, Bou Nassif R, et al
    Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice.
    J Neurooncol. 2017 Jul 1. doi: 10.1007/s11060-017-2551.
    PubMed     Text format     Abstract available


  335. RANDAZZO DM, McSherry F, Herndon JE 2nd, Affronti ML, et al
    A cross sectional analysis from a single institution's experience of psychosocial distress and health-related quality of life in the primary brain tumor population.
    J Neurooncol. 2017 Jul 1. doi: 10.1007/s11060-017-2535.
    PubMed     Text format     Abstract available


    June 2017
  336. LUBGAN D, Rutzner S, Lambrecht U, Rossler K, et al
    Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
    J Neurooncol. 2017 Jun 30. doi: 10.1007/s11060-017-2540.
    PubMed     Text format     Abstract available


  337. AJLAN A, Thomas P, Albakr A, Nagpal S, et al
    Optimizing bevacizumab dosing in glioblastoma: less is more.
    J Neurooncol. 2017 Jun 30. doi: 10.1007/s11060-017-2553.
    PubMed     Text format     Abstract available


  338. MOLITORIS JK, Rao YJ, Patel RA, Kane LT, et al
    Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation.
    J Neurooncol. 2017 Jun 22. doi: 10.1007/s11060-017-2529.
    PubMed     Text format     Abstract available


  339. ZHANG B, Shen C, Ge F, Ma T, et al
    Epigenetically controlled Six3 expression regulates glioblastoma cell proliferation and invasion alongside modulating the activation levels of WNT pathway members.
    J Neurooncol. 2017 Jun 22. doi: 10.1007/s11060-017-2476.
    PubMed     Text format     Abstract available


  340. LEVIN VA, Chan J, Datta M, Yee JL, et al
    Effect of angiotensin system inhibitors on survival in newly diagnosed glioma patients and recurrent glioblastoma patients receiving chemotherapy and/or bevacizumab.
    J Neurooncol. 2017 Jun 19. doi: 10.1007/s11060-017-2528.
    PubMed     Text format     Abstract available


  341. TSANG DS, Murphy ES, Ezell SE, Lucas JT Jr, et al
    Craniospinal irradiation for treatment of metastatic pediatric low-grade glioma.
    J Neurooncol. 2017 Jun 17. doi: 10.1007/s11060-017-2525.
    PubMed     Text format     Abstract available


  342. VASQUEZ JC, Huttner A, Zhang L, Marks A, et al
    SOX2 immunity and tissue resident memory in children and young adults with glioma.
    J Neurooncol. 2017 Jun 15. doi: 10.1007/s11060-017-2515.
    PubMed     Text format     Abstract available


  343. QIN Y, Takahashi M, Sheets K, Soto H, et al
    Epithelial membrane protein-2 (EMP2) promotes angiogenesis in glioblastoma multiforme.
    J Neurooncol. 2017 Jun 9. doi: 10.1007/s11060-017-2507.
    PubMed     Text format     Abstract available


  344. BYRNE S, Connor S, Lascelles K, Siddiqui A, et al
    Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
    J Neurooncol. 2017 Jun 7. doi: 10.1007/s11060-017-2475.
    PubMed     Text format     Abstract available


  345. EL AYOUBI R, Boisselier B, Rousseau A
    Molecular landscape of pediatric diffuse intrinsic pontine gliomas: about 22 cases.
    J Neurooncol. 2017 Jun 6. doi: 10.1007/s11060-017-2523.
    PubMed     Text format    


  346. KUMAR N, Miriyala R, Thakur P, Madan R, et al
    Impact of acute hematological toxicity on treatment interruptions during cranio-spinal irradiation in medulloblastoma: a tertiary care institute experience.
    J Neurooncol. 2017 Jun 2. doi: 10.1007/s11060-017-2524.
    PubMed     Text format     Abstract available


  347. TREVISSON E, Cassina M, Opocher E, Vicenzi V, et al
    Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1.
    J Neurooncol. 2017 Jun 2. doi: 10.1007/s11060-017-2517.
    PubMed     Text format     Abstract available


  348. TRIFILETTI DM, Hill C, Cohen-Inbar O, Xu Z, et al
    Stereotactic radiosurgery for small brain metastases and implications regarding management with systemic therapy alone.
    J Neurooncol. 2017 Jun 2. doi: 10.1007/s11060-017-2519.
    PubMed     Text format     Abstract available


    May 2017
  349. VILLANUEVA-MEYER JE, Han SJ, Cha S, Butowski NA, et al
    Early tumor growth between initial resection and radiotherapy of glioblastoma: incidence and impact on clinical outcomes.
    J Neurooncol. 2017 May 31. doi: 10.1007/s11060-017-2511.
    PubMed     Text format     Abstract available


  350. SAHEBJAM S, Sharabi A, Lim M, Kesarwani P, et al
    Immunotherapy and radiation in glioblastoma.
    J Neurooncol. 2017 May 31. doi: 10.1007/s11060-017-2413.
    PubMed     Text format     Abstract available


  351. KROMER C, Xu J, Ostrom QT, Gittleman H, et al
    Estimating the annual frequency of synchronous brain metastasis in the United States 2010-2013: a population-based study.
    J Neurooncol. 2017 May 31. doi: 10.1007/s11060-017-2516.
    PubMed     Text format     Abstract available


  352. VAN KESSEL E, Baumfalk AE, van Zandvoort MJE, Robe PA, et al
    Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment.
    J Neurooncol. 2017 May 31. doi: 10.1007/s11060-017-2503.
    PubMed     Text format     Abstract available


  353. KUNOS CA, Galanis E, Buchsbaum J, Shi Q, et al
    Radiation-agent combinations for glioblastoma: challenges in drug development and future considerations.
    J Neurooncol. 2017 May 30. doi: 10.1007/s11060-017-2458.
    PubMed     Text format     Abstract available


  354. VELDHUIJZEN VAN ZANTEN SEM, Lane A, Heymans MW, Baugh J, et al
    External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry.
    J Neurooncol. 2017 May 30. doi: 10.1007/s11060-017-2514.
    PubMed     Text format     Abstract available


  355. LI H, Xi Z, Dai X, Wu W, et al
    CD147 and glioma: a meta-analysis.
    J Neurooncol. 2017 May 30. doi: 10.1007/s11060-017-2499.
    PubMed     Text format     Abstract available


  356. BERNHARDT D, Adeberg S, Bozorgmehr F, Opfermann N, et al
    Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
    J Neurooncol. 2017 May 30. doi: 10.1007/s11060-017-2510.
    PubMed     Text format     Abstract available


  357. HAMISCH C, Ruge M, Kellermann S, Kohl AC, et al
    Impact of treatment on survival of patients with secondary glioblastoma.
    J Neurooncol. 2017 May 30. doi: 10.1007/s11060-017-2415.
    PubMed     Text format     Abstract available


  358. KIKUCHI R, Sampetrean O, Saya H, Yoshida K, et al
    Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells.
    J Neurooncol. 2017 May 29. doi: 10.1007/s11060-017-2457.
    PubMed     Text format     Abstract available


  359. CRAIN ID, Elias PS, Chapple K, Scheck AC, et al
    Improving the utility of 1H-MRS for the differentiation of glioma recurrence from radiation necrosis.
    J Neurooncol. 2017 May 29. doi: 10.1007/s11060-017-2407.
    PubMed     Text format     Abstract available


  360. AUER TA, Renovanz M, Marini F, Brockmann MA, et al
    Ischemic stroke and intracranial hemorrhage in patients with recurrent glioblastoma multiforme, treated with bevacizumab.
    J Neurooncol. 2017 May 29. doi: 10.1007/s11060-017-2467.
    PubMed     Text format     Abstract available


  361. SOLER DC, Young AB, Cooper KD, Kerstetter-Fogle A, et al
    The ratio of HLA-DR and VNN2+ expression on CD14+ myeloid derived suppressor cells can distinguish glioblastoma from radiation necrosis patients.
    J Neurooncol. 2017 May 27. doi: 10.1007/s11060-017-2508.
    PubMed     Text format     Abstract available


  362. ZHANG J, Lv J, Zhang F, Che H, et al
    MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma.
    J Neurooncol. 2017 May 27. doi: 10.1007/s11060-017-2464.
    PubMed     Text format     Abstract available


  363. LI Z, Xu C, Ding B, Gao M, et al
    Long non-coding RNA MALAT1 promotes proliferation and suppresses apoptosis of glioma cells through derepressing Rap1B by sponging miR-101.
    J Neurooncol. 2017 May 27. doi: 10.1007/s11060-017-2498.
    PubMed     Text format     Abstract available


  364. ZACHARIA BE, DiStefano N, Mader MM, Chohan MO, et al
    Prior malignancies in patients harboring glioblastoma: an institutional case-study of 2164 patients.
    J Neurooncol. 2017 May 27. doi: 10.1007/s11060-017-2512.
    PubMed     Text format     Abstract available


  365. SITA TL, Petras KG, Wafford QE, Berendsen MA, et al
    Radiotherapy for cranial and brain metastases from prostate cancer: a systematic review.
    J Neurooncol. 2017 May 25. doi: 10.1007/s11060-017-2460.
    PubMed     Text format     Abstract available


  366. WEE CW, Kim E, Kim TM, Park CK, et al
    Impact of interim progression during the surgery-to-radiotherapy interval and its predictors in glioblastoma treated with temozolomide-based radiochemotherapy.
    J Neurooncol. 2017 May 25. doi: 10.1007/s11060-017-2505.
    PubMed     Text format     Abstract available


  367. YANG M, Bai HX, Yang L
    MicroRNA-21 expression in the prognosis of low-grade gliomas: data from the cancer genome atlas (TCGA) project.
    J Neurooncol. 2017 May 25. doi: 10.1007/s11060-017-2500.
    PubMed     Text format    


  368. LEU K, Ott GA, Lai A, Nghiemphu PL, et al
    Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.
    J Neurooncol. 2017 May 25. doi: 10.1007/s11060-017-2506.
    PubMed     Text format     Abstract available


  369. PATEL RA, Bell JB, Kim T, Agulnik M, et al
    Stereotactic radiosurgery for brain metastases from primary head and neck carcinomas: a retrospective analysis.
    J Neurooncol. 2017 May 25. doi: 10.1007/s11060-017-2509.
    PubMed     Text format     Abstract available


  370. BUTTS AM, Weigand S, Brown PD, Petersen RC, et al
    Neurocognition in individuals with incidentally-identified meningioma.
    J Neurooncol. 2017 May 25. doi: 10.1007/s11060-017-2495.
    PubMed     Text format     Abstract available


  371. VAN COEVORDEN-VAN LOON EMP, Coomans MB, Heijenbrok-Kal MH, Ribbers GM, et al
    Fatigue in patients with low grade glioma: systematic evaluation of assessment and prevalence.
    J Neurooncol. 2017 May 24. doi: 10.1007/s11060-017-2454.
    PubMed     Text format     Abstract available


  372. FOURNIER-GOODNIGHT AS, Ashford JM, Merchant TE, Boop FA, et al
    Neurocognitive functioning in pediatric craniopharyngioma: performance before treatment with proton therapy.
    J Neurooncol. 2017 May 24. doi: 10.1007/s11060-017-2492.
    PubMed     Text format     Abstract available


  373. RODRIGUES-SILVA E, Siqueira-Santos ES, Ruas JS, Ignarro RS, et al
    Evaluation of mitochondrial respiratory function in highly glycolytic glioma cells reveals low ADP phosphorylation in relation to oxidative capacity.
    J Neurooncol. 2017 May 24. doi: 10.1007/s11060-017-2482.
    PubMed     Text format     Abstract available


  374. WOLF A, Donahue B, Silverman JS, Chachoua A, et al
    Stereotactic radiosurgery for focal leptomeningeal disease in patients with brain metastases.
    J Neurooncol. 2017 May 23. doi: 10.1007/s11060-017-2497.
    PubMed     Text format     Abstract available


  375. KIM BS, Kong DS, Seol HJ, Nam DH, et al
    MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma.
    J Neurooncol. 2017 May 23. doi: 10.1007/s11060-017-2478.
    PubMed     Text format     Abstract available


  376. PEYRE M, Feuvret L, Sanson M, Navarro S, et al
    Diffuse midline skull base meningiomas: identification of a rare and aggressive subgroup of meningiomas.
    J Neurooncol. 2017 May 23. doi: 10.1007/s11060-017-2480.
    PubMed     Text format     Abstract available


  377. KUNDU P, Li MD, Durkee BY, Hiniker SM, et al
    Chemoradiation impairs normal developmental cortical thinning in medulloblastoma.
    J Neurooncol. 2017 May 22. doi: 10.1007/s11060-017-2453.
    PubMed     Text format     Abstract available


  378. FIELD KM, King MT, Simes J, Espinoza D, et al
    Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma.
    J Neurooncol. 2017 May 22. doi: 10.1007/s11060-017-2479.
    PubMed     Text format     Abstract available


  379. KONDO N, Barth RF, Miyatake SI, Kawabata S, et al
    Cerebrospinal fluid dissemination of high-grade gliomas following boron neutron capture therapy occurs more frequently in the small cell subtype of IDH1R132H mutation-negative glioblastoma.
    J Neurooncol. 2017 May 22. doi: 10.1007/s11060-017-2408.
    PubMed     Text format     Abstract available


  380. SONODA Y, Shibahara I, Matsuda KI, Saito R, et al
    Opening the ventricle during surgery diminishes survival among patients with newly diagnosed glioblastoma treated with carmustine wafers: a multi-center retrospective study.
    J Neurooncol. 2017 May 22. doi: 10.1007/s11060-017-2488.
    PubMed     Text format     Abstract available


  381. KUCHINAD KE, Strowd R, Evans A, Riley WA, et al
    End of life care for glioblastoma patients at a large academic cancer center.
    J Neurooncol. 2017 May 20. doi: 10.1007/s11060-017-2487.
    PubMed     Text format     Abstract available


  382. GLASER SM, Dohopolski MJ, Balasubramani GK, Flickinger JC, et al
    Glioblastoma multiforme (GBM) in the elderly: initial treatment strategy and overall survival.
    J Neurooncol. 2017 May 19. doi: 10.1007/s11060-017-2493.
    PubMed     Text format     Abstract available


  383. VOSS KM, Spille DC, Sauerland C, Molina ES, et al
    The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value?
    J Neurooncol. 2017 May 19. doi: 10.1007/s11060-017-2481.
    PubMed     Text format     Abstract available


  384. DIAZ RJ, Ali S, Qadir MG, De La Fuente MI, et al
    The role of bevacizumab in the treatment of glioblastoma.
    J Neurooncol. 2017 May 19. doi: 10.1007/s11060-017-2477.
    PubMed     Text format     Abstract available


  385. RENOVANZ M, Hechtner M, Janko M, Kohlmann K, et al
    Factors associated with supportive care needs in glioma patients in the neuro-oncological outpatient setting.
    J Neurooncol. 2017 May 19. doi: 10.1007/s11060-017-2484.
    PubMed     Text format     Abstract available


  386. ESEONU CI, Eguia F, ReFaey K, Garcia O, et al
    Comparative volumetric analysis of the extent of resection of molecularly and histologically distinct low grade gliomas and its role on survival.
    J Neurooncol. 2017 May 19. doi: 10.1007/s11060-017-2486.
    PubMed     Text format     Abstract available


  387. YUAN G, Niu L, Zhang Y, Wang X, et al
    Defining optimal cutoff value of MGMT promoter methylation by ROC analysis for clinical setting in glioblastoma patients.
    J Neurooncol. 2017 May 17. doi: 10.1007/s11060-017-2433.
    PubMed     Text format     Abstract available


  388. WION D
    Therapeutic dormancy to delay postsurgical glioma recurrence: the past, present and promise of focal hypothermia.
    J Neurooncol. 2017 May 17. doi: 10.1007/s11060-017-2471.
    PubMed     Text format     Abstract available


  389. KUMTHEKAR P, Grimm S, Chandler J, Mehta M, et al
    A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas.
    J Neurooncol. 2017 May 16. doi: 10.1007/s11060-017-2469.
    PubMed     Text format     Abstract available


  390. STORY E, Johnston DL, Bartels U, Carret AS, et al
    Embryonal tumors in Canadian children less than 36 months of age: results from the Canadian Pediatric Brain Tumor Consortium (CPBTC).
    J Neurooncol. 2017 May 16. doi: 10.1007/s11060-017-2468.
    PubMed     Text format     Abstract available


  391. JIN C, Li M, Ouyang Y, Tan Z, et al
    MiR-424 functions as a tumor suppressor in glioma cells and is down-regulated by DNA methylation.
    J Neurooncol. 2017 May 15. doi: 10.1007/s11060-017-2438.
    PubMed     Text format     Abstract available


  392. GESSLER F, Baumgarten P, Bernstock JD, Harter P, et al
    Assessment of molecular markers demonstrates concordance between samples acquired via stereotactic biopsy and open craniotomy in both anaplastic astrocytomas and glioblastomas.
    J Neurooncol. 2017 May 15. doi: 10.1007/s11060-017-2448.
    PubMed     Text format     Abstract available


  393. CHEN Y, Li R, Pan M, Shi Z, et al
    MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor.
    J Neurooncol. 2017 May 13. doi: 10.1007/s11060-017-2463.
    PubMed     Text format     Abstract available


  394. FONTANA AO, Piffaretti D, Marchi F, Burgio F, et al
    Epithelial growth factor receptor expression influences 5-ALA induced glioblastoma fluorescence.
    J Neurooncol. 2017 May 12. doi: 10.1007/s11060-017-2474.
    PubMed     Text format     Abstract available


  395. MALGULWAR PB, Nambirajan A, Pathak P, Faruq M, et al
    Study of beta-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases.
    J Neurooncol. 2017 May 12. doi: 10.1007/s11060-017-2465.
    PubMed     Text format     Abstract available


  396. CHAMBERLAIN MC, Kim BT
    Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series.
    J Neurooncol. 2017 May 12. doi: 10.1007/s11060-017-2466.
    PubMed     Text format     Abstract available


  397. BALENDRAN S, Liebmann-Reindl S, Berghoff AS, Reischer T, et al
    Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutations.
    J Neurooncol. 2017 May 11. doi: 10.1007/s11060-017-2459.
    PubMed     Text format     Abstract available


  398. VECHT C, Duran-Pena A, Houillier C, Durand T, et al
    Seizure response to perampanel in drug-resistant epilepsy with gliomas: early observations.
    J Neurooncol. 2017 May 10. doi: 10.1007/s11060-017-2473.
    PubMed     Text format     Abstract available


  399. ARNESON K, Mondschein J, Stavas M, Cmelak AJ, et al
    A phase I trial of concurrent sorafenib and stereotactic radiosurgery for patients with brain metastases.
    J Neurooncol. 2017 May 9. doi: 10.1007/s11060-017-2455.
    PubMed     Text format     Abstract available


  400. QIAO W, Zhao L, Wu S, Liu C, et al
    SPECT imaging and radionuclide therapy of glioma using 131I labeled Buthus martensii Karsch chlorotoxin.
    J Neurooncol. 2017 May 9. doi: 10.1007/s11060-017-2456.
    PubMed     Text format     Abstract available


  401. MAZUROWSKI MA, Clark K, Czarnek NM, Shamsesfandabadi P, et al
    Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with The Cancer Genome Atlas data.
    J Neurooncol. 2017 May 3. doi: 10.1007/s11060-017-2420.
    PubMed     Text format     Abstract available


  402. AHMED KA, Kim S, Arrington J, Naghavi AO, et al
    Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases.
    J Neurooncol. 2017 May 2. doi: 10.1007/s11060-017-2437.
    PubMed     Text format     Abstract available


    April 2017
  403. SCRIBNER E, Hackney JR, Machemehl HC, Afiouni R, et al
    Key rates for the grades and transformation ability of glioma: model simulations and clinical cases.
    J Neurooncol. 2017 Apr 27. doi: 10.1007/s11060-017-2444.
    PubMed     Text format     Abstract available


  404. MIYAZAKI T, Ishikawa E, Matsuda M, Akutsu H, et al
    Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome.
    J Neurooncol. 2017 Apr 26. doi: 10.1007/s11060-017-2451.
    PubMed     Text format     Abstract available


  405. HAN H, Han C, Wu X, Zhong S, et al
    Preoperative grading of supratentorial nonenhancing gliomas by high b-value diffusion-weighted 3 T magnetic resonance imaging.
    J Neurooncol. 2017 Apr 24. doi: 10.1007/s11060-017-2423.
    PubMed     Text format     Abstract available


  406. DARLIX A, Deverdun J, Menjot de Champfleur N, Castan F, et al
    IDH mutation and 1p19q codeletion distinguish two radiological patterns of diffuse low-grade gliomas.
    J Neurooncol. 2017 Apr 22. doi: 10.1007/s11060-017-2421.
    PubMed     Text format     Abstract available


  407. YANO H, Nakayama N, Ohe N, Miwa K, et al
    Pathological analysis of the surgical margins of resected glioblastomas excised using photodynamic visualization with both 5-aminolevulinic acid and fluorescein sodium.
    J Neurooncol. 2017 Apr 21. doi: 10.1007/s11060-017-2445.
    PubMed     Text format     Abstract available


  408. EMERY IF, Gopalan A, Wood S, Chow KH, et al
    Expression and function of ABCG2 and XIAP in glioblastomas.
    J Neurooncol. 2017 Apr 21. doi: 10.1007/s11060-017-2422.
    PubMed     Text format     Abstract available


  409. HAQUE W, Verma V, Butler EB, Teh BS, et al
    Patterns of care and outcomes of multi-agent versus single-agent chemotherapy as part of multimodal management of low grade glioma.
    J Neurooncol. 2017 Apr 21. doi: 10.1007/s11060-017-2443.
    PubMed     Text format     Abstract available


  410. YOULAND RS, Schomas DA, Brown PD, Parney IF, et al
    Patterns of care and treatment outcomes in older adults with low grade glioma: a 50-year experience.
    J Neurooncol. 2017 Apr 21. doi: 10.1007/s11060-017-2439.
    PubMed     Text format     Abstract available


  411. WU L, Yang C, Liu T, Fang J, et al
    Clinical features and long-term outcomes of pediatric spinal meningiomas.
    J Neurooncol. 2017 Apr 21. doi: 10.1007/s11060-017-2441.
    PubMed     Text format     Abstract available


  412. BUGLIONE M, Triggiani L, Magrini SM
    The growing role of biology in the treatment of glioblastoma: no more one kind of disease.
    J Neurooncol. 2017 Apr 20. doi: 10.1007/s11060-017-2417.
    PubMed     Text format    


  413. GARZON-MUVDI T, Yang W, Lim M, Brem H, et al
    Atypical and anaplastic meningioma: outcomes in a population based study.
    J Neurooncol. 2017 Apr 20. doi: 10.1007/s11060-017-2436.
    PubMed     Text format     Abstract available


  414. KEIL VC, Pintea B, Gielen GH, Greschus S, et al
    Biopsy targeting with dynamic contrast-enhanced versus standard neuronavigation MRI in glioma: a prospective double-blinded evaluation of selection benefits.
    J Neurooncol. 2017 Apr 19. doi: 10.1007/s11060-017-2424.
    PubMed     Text format     Abstract available


  415. NIE E, Jin X, Wu W, Yu T, et al
    MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT.
    J Neurooncol. 2017 Apr 19. doi: 10.1007/s11060-017-2425.
    PubMed     Text format     Abstract available


  416. HUANG X, Bai HX, Yang L
    ZEB1 expression in Chinese lower-grade gliomas.
    J Neurooncol. 2017 Apr 18. doi: 10.1007/s11060-017-2419.
    PubMed     Text format    


  417. BOISSELIER B, De Carli E, Rousseau A
    Molecular alterations in pediatric gliomatosis cerebri are similar to those in less invasive forms of pediatric diffuse glioma.
    J Neurooncol. 2017 Apr 18. doi: 10.1007/s11060-017-2432.
    PubMed     Text format    


  418. NGUYEN J, Hossain SS, Cooke JRN, Ellis JA, et al
    Flow arrest intra-arterial delivery of small TAT-decorated and neutral micelles to gliomas.
    J Neurooncol. 2017 Apr 18. doi: 10.1007/s11060-017-2429.
    PubMed     Text format     Abstract available


  419. RICHARDSON TE, Snuderl M, Serrano J, Karajannis MA, et al
    Rapid progression to glioblastoma in a subset of IDH-mutated astrocytomas: a genome-wide analysis.
    J Neurooncol. 2017 Apr 18. doi: 10.1007/s11060-017-2431.
    PubMed     Text format     Abstract available


  420. KIM Y, Do IG, Hong M, Suh YL, et al
    Negative prognostic effect of low nuclear GLI1 expression in glioblastomas.
    J Neurooncol. 2017 Apr 17. doi: 10.1007/s11060-017-2426.
    PubMed     Text format     Abstract available


  421. FAY-MCCLYMONT TB, Ploetz DM, Mabbott D, Walsh K, et al
    Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach.
    J Neurooncol. 2017 Apr 12. doi: 10.1007/s11060-017-2409.
    PubMed     Text format     Abstract available


  422. WIJNENGA MM, Mattni T, French PJ, Rutten GJ, et al
    Does early resection of presumed low-grade glioma improve survival? A clinical perspective.
    J Neurooncol. 2017 Apr 11. doi: 10.1007/s11060-017-2418.
    PubMed     Text format     Abstract available


  423. LI H, Lian J, Jin H, Wang W, et al
    Assessment of prognostic scores of brain metastases from lung adenocarcinoma with EGFR mutations.
    J Neurooncol. 2017 Apr 8. doi: 10.1007/s11060-017-2411.
    PubMed     Text format     Abstract available


  424. HOWARD SP, Krauze A, Chan MD, Tsien C, et al
    The evolving role for re-irradiation in the management of recurrent grade 4 glioma.
    J Neurooncol. 2017 Apr 6. doi: 10.1007/s11060-017-2392.
    PubMed     Text format     Abstract available


  425. TINI P, Nardone V, Pirtoli L
    Is there a potential role for EGFR expression to lead margin reduction in glioblastoma?
    J Neurooncol. 2017 Apr 5. doi: 10.1007/s11060-017-2406.
    PubMed     Text format    


  426. ELLINGSON BM, Chung C, Pope WB, Boxerman JL, et al
    Pseudoprogression, radionecrosis, inflammation or true tumor progression? challenges associated with glioblastoma response assessment in an evolving therapeutic landscape.
    J Neurooncol. 2017 Apr 5. doi: 10.1007/s11060-017-2375.
    PubMed     Text format     Abstract available


  427. AZOULAY M, Santos F, Shenouda G, Petrecca K, et al
    Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
    J Neurooncol. 2017 Apr 3. doi: 10.1007/s11060-017-2383.
    PubMed     Text format     Abstract available


  428. LAZARI D, Alexiou GA, Markopoulos GS, Vartholomatos E, et al
    N-(p-coumaroyl) serotonin inhibits glioblastoma cells growth through triggering S-phase arrest and apoptosis.
    J Neurooncol. 2017 Apr 1. doi: 10.1007/s11060-017-2382.
    PubMed     Text format     Abstract available


  429. YAO X, Gao H, Li C, Wu L, et al
    Analysis of Ki67, HMGA1, MDM2, and RB expression in nonfunctioning pituitary adenomas.
    J Neurooncol. 2017;132:199-206.
    PubMed     Text format     Abstract available


  430. VELDHUIJZEN VAN ZANTEN SE, Baugh J, Chaney B, De Jongh D, et al
    Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease.
    J Neurooncol. 2017;132:255-266.
    PubMed     Text format     Abstract available


    March 2017
  431. BRAUNSTEIN S, Raleigh D, Bindra R, Mueller S, et al
    Pediatric high-grade glioma: current molecular landscape and therapeutic approaches.
    J Neurooncol. 2017 Mar 29. doi: 10.1007/s11060-017-2393.
    PubMed     Text format     Abstract available


  432. ALTUNDAG K
    Radio-sensitising effect of T-DM1 should not be discarded for the efficacy of radiosurgery in the management of brain metastases in patients with HER2-positive metastatic breast cancer.
    J Neurooncol. 2017 Mar 23. doi: 10.1007/s11060-017-2405.
    PubMed     Text format    


  433. MASON M, Maurice C, McNamara MG, Tieu MT, et al
    Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival.
    J Neurooncol. 2017 Mar 22. doi: 10.1007/s11060-017-2395.
    PubMed     Text format     Abstract available


  434. LIU H, Liu B, Hou X, Pang B, et al
    Overexpression of NIMA-related kinase 2 is associated with poor prognoses in malignant glioma.
    J Neurooncol. 2017 Mar 21. doi: 10.1007/s11060-017-2401.
    PubMed     Text format     Abstract available


  435. ERWOOD AA, Velazquez-Vega JE, Neill S, Solomon DA, et al
    Chordoid glioma of the third ventricle: report of a rapidly progressive case.
    J Neurooncol. 2017 Mar 18. doi: 10.1007/s11060-017-2399.
    PubMed     Text format     Abstract available


  436. ZHANG P, Sun S, Li N, Ho AS, et al
    Rutin increases the cytotoxicity of temozolomide in glioblastoma via autophagy inhibition.
    J Neurooncol. 2017 Mar 14. doi: 10.1007/s11060-017-2387.
    PubMed     Text format     Abstract available


  437. SINNADURAI M, McDonald KL
    Immune checkpoint inhibition and its relationship with hypermutation phenoytype as a potential treatment for Glioblastoma.
    J Neurooncol. 2017 Mar 14. doi: 10.1007/s11060-017-2390.
    PubMed     Text format     Abstract available


  438. DRESSLER EV, Dolecek TA, Liu M, Villano JL, et al
    Demographics, patterns of care, and survival in pediatric medulloblastoma.
    J Neurooncol. 2017 Mar 13. doi: 10.1007/s11060-017-2400.
    PubMed     Text format     Abstract available


  439. MEYER RM, Miller CA, Coughlin DJ, Rymarczuk G, et al
    Glioblastoma recurrence, progression, and dissemination as a purely subdural gliosarcoma.
    J Neurooncol. 2017 Mar 13. doi: 10.1007/s11060-017-2397.
    PubMed     Text format    


  440. KNEBEL FH, Uno M, Galatro TF, Belle LP, et al
    Serum amyloid A1 is upregulated in human glioblastoma.
    J Neurooncol. 2017 Mar 11. doi: 10.1007/s11060-017-2386.
    PubMed     Text format     Abstract available


  441. SATO A, Mizobuchi Y, Nakajima K, Shono K, et al
    Blocking COX-2 induces apoptosis and inhibits cell proliferation via the Akt/survivin- and Akt/ID3 pathway in low-grade-glioma.
    J Neurooncol. 2017 Mar 10. doi: 10.1007/s11060-017-2380.
    PubMed     Text format     Abstract available


  442. DONG X, Tamura K, Kobayashi D, Ando N, et al
    Erratum to: LAPTM4B-35 is a novel prognostic factor for glioblastoma.
    J Neurooncol. 2017 Mar 9. doi: 10.1007/s11060-017-2381.
    PubMed     Text format    


  443. QIAN JM, Mahajan A, Yu JB, Tsiouris AJ, et al
    Comparing available criteria for measuring brain metastasis response to immunotherapy.
    J Neurooncol. 2017 Mar 8. doi: 10.1007/s11060-017-2398.
    PubMed     Text format     Abstract available


  444. CORSO CD, Bindra RS, Mehta MP
    The role of radiation in treating glioblastoma: here to stay.
    J Neurooncol. 2017 Mar 7. doi: 10.1007/s11060-016-2348.
    PubMed     Text format     Abstract available


  445. FARINA P, Tabouret E, Lehmann P, Barrie M, et al
    Relationship between magnetic resonance imaging characteristics and plasmatic levels of MMP2 and MMP9 in patients with recurrent high-grade gliomas treated by Bevacizumab and Irinotecan.
    J Neurooncol. 2017 Mar 6. doi: 10.1007/s11060-017-2385.
    PubMed     Text format     Abstract available


  446. MINNITI G, Paolini S, D'Andrea G, Lanzetta G, et al
    Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases.
    J Neurooncol. 2017 Mar 4. doi: 10.1007/s11060-017-2394.
    PubMed     Text format     Abstract available


  447. DEB S, Pendharkar AV, Schoen MK, Altekruse S, et al
    The effect of socioeconomic status on gross total resection, radiation therapy and overall survival in patients with gliomas.
    J Neurooncol. 2017 Mar 3. doi: 10.1007/s11060-017-2391.
    PubMed     Text format     Abstract available


  448. ALTUNDAG K
    Tumor types, breast tumor subtypes and extension of systemic disease may influence outcome in cancer patients with brain metastases.
    J Neurooncol. 2017 Mar 2. doi: 10.1007/s11060-017-2402.
    PubMed     Text format    


  449. CLONEY MB, Sonabend AM, Yun J, Yang J, et al
    The safety of resection for primary central nervous system lymphoma: a single institution retrospective analysis.
    J Neurooncol. 2017;132:189-197.
    PubMed     Text format     Abstract available


  450. CHON H, Yoon K, Kwon DH, Kim CJ, et al
    Hypofractionated stereotactic radiosurgery for pituitary metastases.
    J Neurooncol. 2017;132:127-133.
    PubMed     Text format     Abstract available


  451. THOMPSON EM, Gururangan S, Grant G, Mitchell D, et al
    The clinical and financial impact of a pediatric surgical neuro-oncology clinical trial.
    J Neurooncol. 2017;132:83-87.
    PubMed     Text format     Abstract available


  452. XU L, Ouyang Z, Wang J, Liu Z, et al
    A clinicopathologic study of extraventricular neurocytoma.
    J Neurooncol. 2017;132:75-82.
    PubMed     Text format     Abstract available


    February 2017
  453. LUDWIG K, Kornblum HI
    Molecular markers in glioma.
    J Neurooncol. 2017 Feb 23. doi: 10.1007/s11060-017-2379.
    PubMed     Text format     Abstract available


  454. CHAMBERLAIN MC, Colman H, Kim BT, Raizer J, et al
    Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trial.
    J Neurooncol. 2017 Feb 16. doi: 10.1007/s11060-016-2241.
    PubMed     Text format     Abstract available


  455. ROWSE AL, Gibson SA, Meares GP, Rajbhandari R, et al
    Protein kinase CK2 is important for the function of glioblastoma brain tumor initiating cells.
    J Neurooncol. 2017 Feb 8. doi: 10.1007/s11060-017-2378.
    PubMed     Text format     Abstract available


  456. LEE J, Solomon DA, Tihan T
    Erratum to: The role of histone modifications and telomere alterations in the pathogenesis of diffuse gliomas in adults and children.
    J Neurooncol. 2017 Feb 7. doi: 10.1007/s11060-017-2376.
    PubMed     Text format    


  457. SHABIHKHANI M, Telesca D, Movassaghi M, Naeini YB, et al
    Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma.
    J Neurooncol. 2017 Feb 4. doi: 10.1007/s11060-017-2377.
    PubMed     Text format     Abstract available


  458. OORT Q, Dirven L, Meijer W, Sikkes SA, et al
    Development of a questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumors: a pilot study.
    J Neurooncol. 2017 Feb 1. doi: 10.1007/s11060-016-2352.
    PubMed     Text format     Abstract available


  459. FAN W, Wang W, Mao X, Chu S, et al
    Elevated levels of p-Mnk1, p-eIF4E and p-p70S6K proteins are associated with tumor recurrence and poor prognosis in astrocytomas.
    J Neurooncol. 2017;131:485-493.
    PubMed     Text format     Abstract available


  460. DESAI B, Hobbs J, Hartung G, Xu G, et al
    Image-guidance technology and the surgical resection of spinal column tumors.
    J Neurooncol. 2017;131:425-435.
    PubMed     Text format     Abstract available


  461. CHAN V, Sahgal A, Egeto P, Schweizer T, et al
    Incidence of seizure in adult patients with intracranial metastatic disease.
    J Neurooncol. 2017;131:619-624.
    PubMed     Text format     Abstract available


  462. KESLER SR, Noll K, Cahill DP, Rao G, et al
    The effect of IDH1 mutation on the structural connectome in malignant astrocytoma.
    J Neurooncol. 2017;131:565-574.
    PubMed     Text format     Abstract available


  463. BESPALOV VG, Alexandrov VA, Vysochina GI, Kostikova Vcapital A, Cyrillic, et al
    The inhibiting activity of meadowsweet extract on neurocarcinogenesis induced transplacentally in rats by ethylnitrosourea.
    J Neurooncol. 2017;131:459-467.
    PubMed     Text format     Abstract available


    January 2017
  464. NEILL E, Luks T, Dayal M, Phillips JJ, et al
    Quantitative multi-modal MR imaging as a non-invasive prognostic tool for patients with recurrent low-grade glioma.
    J Neurooncol. 2017 Jan 25. doi: 10.1007/s11060-016-2355.
    PubMed     Text format     Abstract available


  465. NAYAK L, de Groot J, Wefel JS, Cloughesy TF, et al
    Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas.
    J Neurooncol. 2017 Jan 23. doi: 10.1007/s11060-016-2357.
    PubMed     Text format     Abstract available


  466. MCGAHAN BG, Neilsen BK, Kelly DL, McComb RD, et al
    Assessment of vascularity in glioblastoma and its implications on patient outcomes.
    J Neurooncol. 2017 Jan 19. doi: 10.1007/s11060-016-2350.
    PubMed     Text format     Abstract available


  467. FLEISCHMANN DF, Unterrainer M, Bartenstein P, Belka C, et al
    18F-FET PET prior to recurrent high-grade glioma re-irradiation-additional prognostic value of dynamic time-to-peak analysis and early static summation images?
    J Neurooncol. 2017 Jan 19. doi: 10.1007/s11060-016-2366.
    PubMed     Text format     Abstract available


  468. MERKEL A, Soeldner D, Wendl C, Urkan D, et al
    Early postoperative tumor progression predicts clinical outcome in glioblastoma-implication for clinical trials.
    J Neurooncol. 2017 Jan 18. doi: 10.1007/s11060-016-2362.
    PubMed     Text format     Abstract available


  469. DONG X, Tamura K, Kobayashi D, Ando N, et al
    LAPTM4B-35 is a novel prognostic factor for glioblastoma.
    J Neurooncol. 2017 Jan 18. doi: 10.1007/s11060-017-2369.
    PubMed     Text format     Abstract available


  470. BAUGH J, Bartels U, Leach J, Jones B, et al
    The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease.
    J Neurooncol. 2017 Jan 16. doi: 10.1007/s11060-017-2372.
    PubMed     Text format     Abstract available


  471. CHENG W, Ren X, Zhang C, Han S, et al
    Expression and prognostic value of microRNAs in lower-grade glioma depends on IDH1/2 status.
    J Neurooncol. 2017 Jan 16. doi: 10.1007/s11060-016-2368.
    PubMed     Text format     Abstract available


  472. MUNTHE S, Halle B, Boldt HB, Christiansen H, et al
    Shift of microRNA profile upon glioma cell migration using patient-derived spheroids and serum-free conditions.
    J Neurooncol. 2017 Jan 13. doi: 10.1007/s11060-016-2356.
    PubMed     Text format     Abstract available


  473. XAVIER-MAGALHAES A, Oliveira AI, de Castro JV, Pojo M, et al
    Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis.
    J Neurooncol. 2017 Jan 12. doi: 10.1007/s11060-016-2345.
    PubMed     Text format     Abstract available


  474. HE ZQ, Ke C, Al-Nahari F, Duan H, et al
    Low preoperative prognostic nutritional index predicts poor survival in patients with newly diagnosed high-grade gliomas.
    J Neurooncol. 2017 Jan 11. doi: 10.1007/s11060-016-2361.
    PubMed     Text format     Abstract available


  475. LUCAS JT JR, Serrano N, Kim H, Li X, et al
    11C-Methionine positron emission tomography delineates non-contrast enhancing tumor regions at high risk for recurrence in pediatric high-grade glioma.
    J Neurooncol. 2017 Jan 11. doi: 10.1007/s11060-016-2354.
    PubMed     Text format     Abstract available


  476. ARTZI M, Liberman G, Vaisman N, Bokstein F, et al
    Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors: 1H-MRS study.
    J Neurooncol. 2017 Jan 10. doi: 10.1007/s11060-016-2364.
    PubMed     Text format     Abstract available


  477. MISTRY AM, Dewan MC, White-Dzuro GA, Brinson PR, et al
    Decreased survival in glioblastomas is specific to contact with the ventricular-subventricular zone, not subgranular zone or corpus callosum.
    J Neurooncol. 2017 Jan 10. doi: 10.1007/s11060-017-2374.
    PubMed     Text format     Abstract available


  478. NA YC, Jung HH, Kim HR, Cho BC, et al
    Predictive factors of early distant brain failure after gamma knife radiosurgery alone in patients with brain metastases of non-small-cell lung cancer.
    J Neurooncol. 2017 Jan 10. doi: 10.1007/s11060-017-2373.
    PubMed     Text format     Abstract available


  479. CZARNEK N, Clark K, Peters KB, Mazurowski MA, et al
    Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study.
    J Neurooncol. 2017 Jan 10. doi: 10.1007/s11060-016-2359.
    PubMed     Text format     Abstract available


  480. PINEL B, Duchesne M, Godet J, Milin S, et al
    Mesenchymal subtype of glioblastomas with high DNA-PKcs expression is associated with better response to radiotherapy and temozolomide.
    J Neurooncol. 2017 Jan 10. doi: 10.1007/s11060-016-2367.
    PubMed     Text format     Abstract available


  481. SAITO K, Ohta S, Kawakami Y, Yoshida K, et al
    Functional analysis of KIF20A, a potential immunotherapeutic target for glioma.
    J Neurooncol. 2017 Jan 9. doi: 10.1007/s11060-016-2360.
    PubMed     Text format     Abstract available


  482. LEE J, Solomon DA, Tihan T
    The role of histone modifications and telomere alterations in the pathogenesis of diffuse gliomas in adults and children.
    J Neurooncol. 2017 Jan 7. doi: 10.1007/s11060-016-2349.
    PubMed     Text format     Abstract available


  483. OH ME, Driever PH, Khajuria RK, Rueckriegel SM, et al
    DTI fiber tractography of cerebro-cerebellar pathways and clinical evaluation of ataxia in childhood posterior fossa tumor survivors.
    J Neurooncol. 2017;131:267-276.
    PubMed     Text format     Abstract available


  484. MOLAD JA, Blumenthal DT, Bokstein F, Findler M, et al
    Mechanisms of post-radiation injury: cerebral microinfarction not a significant factor.
    J Neurooncol. 2017;131:277-281.
    PubMed     Text format     Abstract available


  485. RICCI S, Guadagno E, Bruzzese D, Del Basso De Caro M, et al
    Evaluation of matrix metalloproteinase type IV-collagenases in serum of patients with tumors of the central nervous system.
    J Neurooncol. 2017;131:223-232.
    PubMed     Text format     Abstract available


  486. KUITUNEN H, Tokola S, Siniluoto T, Isokangas M, et al
    Promising treatment results with blood brain barrier disruption (BBBD) based immunochemotherapy combined with autologous stem cell transplantation (ASCT) in patients with primary central nervous system lymphoma (PCNSL).
    J Neurooncol. 2017;131:293-300.
    PubMed     Text format     Abstract available


  487. GEORGAKIS MK, Karalexi MA, Kalogirou EI, Ryzhov A, et al
    Incidence, time trends and survival patterns of childhood pilocytic astrocytomas in Southern-Eastern Europe and SEER, US.
    J Neurooncol. 2017;131:163-175.
    PubMed     Text format     Abstract available


  488. ZENG L, Wang Y, Wang Y, Han L, et al
    Analyses of prognosis-related factors of intracranial solitary fibrous tumors and hemangiopericytomas help understand the relationship between the two sorts of tumors.
    J Neurooncol. 2017;131:153-161.
    PubMed     Text format     Abstract available


  489. TABATABAEI P, Visse E, Bergstrom P, Brannstrom T, et al
    Radiotherapy induces an immediate inflammatory reaction in malignant glioma: a clinical microdialysis study.
    J Neurooncol. 2017;131:83-92.
    PubMed     Text format     Abstract available


    December 2016
  490. HAYASHI S, Kitamura Y, Hirose Y, Yoshida K, et al
    Molecular-genetic and clinicopathological prognostic factors in patients with gliomas showing total 1p19q loss: gain of chromosome 19p and histological grade III negatively correlate with patient's prognosis.
    J Neurooncol. 2016 Dec 26. doi: 10.1007/s11060-016-2344.
    PubMed     Text format     Abstract available


  491. RAO YJ, Hassanzadeh C, Fischer-Valuck B, Chicoine MR, et al
    Patterns of care and treatment outcomes of patients with Craniopharyngioma in the national cancer database.
    J Neurooncol. 2016 Dec 23. doi: 10.1007/s11060-016-2342.
    PubMed     Text format     Abstract available


  492. LI J, Ren S, Liu Y, Lian Z, et al
    Knockdown of NUPR1 inhibits the proliferation of glioblastoma cells via ERK1/2, p38 MAPK and caspase-3.
    J Neurooncol. 2016 Dec 20. doi: 10.1007/s11060-016-2337.
    PubMed     Text format     Abstract available


  493. PATEL KR, Burri SH, Boselli D, Symanowski JT, et al
    Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis.
    J Neurooncol. 2016 Dec 20. doi: 10.1007/s11060-016-2334.
    PubMed     Text format     Abstract available


  494. GERAUD A, Xu HP, Beuzeboc P, Kirova YM, et al
    Preliminary experience of the concurrent use of radiosurgery and T-DM1 for brain metastases in HER2-positive metastatic breast cancer.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  495. WEIL AG, Wang AC, Westwick HJ, Ibrahim GM, et al
    Survival in pediatric medulloblastoma: a population-based observational study to improve prognostication.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  496. DARLIX A, Zouaoui S, Rigau V, Bessaoud F, et al
    Erratum to: Epidemiology for primary brain tumors: a nationwide population-based study.
    J Neurooncol. 2016.
    PubMed     Text format    


    November 2016
  497. BENNETT IE, Field KM, Hovens CM, Moffat BA, et al
    Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  498. WINTHER TL, Torp SH
    MCM7 expression is a promising predictor of recurrence in patients surgically resected for meningiomas.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  499. KARHADE AV, Fandino L, Gupta S, Cote DJ, et al
    Impact of operative length on post-operative complications in meningioma surgery: a NSQIP analysis.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  500. BALASUBRAMANIAN SK, Sharma M, Silva D, Karivedu V, et al
    Longitudinal experience with WHO Grade III (anaplastic) meningiomas at a single institution.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  501. AHLUWALIA MS, Bou-Anak S, Burgett ME, Sarmey N, et al
    Correlation of higher levels of soluble TNF-R1 with a shorter survival, independent of age, in recurrent glioblastoma.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  502. HUTTER G, Sailer M, Azad TD, von Bueren AO, et al
    Reverse phase protein arrays enable glioblastoma molecular subtyping.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  503. KALPATHY-CRAMER J, Chandra V, Da X, Ou Y, et al
    Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  504. DARLIX A, Zouaoui S, Rigau V, Bessaoud F, et al
    Epidemiology for primary brain tumors: a nationwide population-based study.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  505. GRIGUOLO G, Dieci MV, Giarratano T, Giorgi CA, et al
    Beyond breast specific-Graded Prognostic Assessment in patients with brain metastases from breast cancer: treatment impact on outcome.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  506. ISMAIL FS, Moinfar Z, Prochnow N, Dambach H, et al
    Dexamethasone and levetiracetam reduce hetero-cellular gap-junctional coupling between F98 glioma cells and glial cells in vitro.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  507. ZHANG J, Yao TW, Hashizume R, Hariono S, et al
    Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  508. PHUPHANICH S, Raizer J, Chamberlain M, Canelos P, et al
    Phase II study of MEDI-575, an anti-platelet-derived growth factor-alpha antibody, in patients with recurrent glioblastoma.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  509. PERRINI P, Gambacciani C, Weiss A, Pasqualetti F, et al
    Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  510. ZAKARIA R, Pomschar A, Jenkinson MD, Tonn JC, et al
    Use of diffusion-weighted MRI to modify radiosurgery planning in brain metastases may reduce local recurrence.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  511. HUANG J, Samson P, Perkins SM, Ansstas G, et al
    Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  512. BO HK, Solheim O, Jakola AS, Kvistad KA, et al
    Intra-rater variability in low-grade glioma segmentation.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  513. DHAMI J, Chang E, Gambhir SS
    Withaferin A and its potential role in glioblastoma (GBM).
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  514. YANG JK, Yang JP, Tong J, Jing SY, et al
    Exosomal miR-221 targets DNM3 to induce tumor progression and temozolomide resistance in glioma.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  515. NAKAE S, Murayama K, Sasaki H, Kumon M, et al
    Prediction of genetic subgroups in adult supra tentorial gliomas by pre- and intraoperative parameters.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  516. HASEGAWA T, Kato T, Yamamoto T, Iizuka H, et al
    Multisession gamma knife surgery for large brain metastases.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  517. BUNEVICIUS A, Laws ER, Deltuva V, Tamasauskas A, et al
    Association of thyroid hormone concentrations with quality of life of primary brain tumor patients: a pilot study.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  518. PESSINA F, Navarria P, Cozzi L, Tomatis S, et al
    Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  519. PAN E, Supko JG, Kaley TJ, Butowski NA, et al
    Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  520. BORDIA R, Zhong H, Lee J, Weiss S, et al
    Melanoma brain metastases: correlation of imaging features with genomic markers and patient survival.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  521. BIRCKHEAD B, Sio TT, Pollock BE, Link MJ, et al
    Gamma Knife radiosurgery for neurofibromatosis type 2-associated meningiomas: a 22-year patient series.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  522. KUROKAWA C, Geekiyanage H, Allen C, Iankov I, et al
    Alisertib demonstrates significant antitumor activity in bevacizumab resistant, patient derived orthotopic models of glioblastoma.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  523. MELLAI M, Annovazzi L, Senetta R, Dell'Aglio C, et al
    Diagnostic revision of 206 adult gliomas (including 40 oligoastrocytomas) based on ATRX, IDH1/2 and 1p/19q status.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  524. CIKANKOWITZ A, Clavreul A, Tetaud C, Lemaire L, et al
    Characterization of the distribution, retention, and efficacy of internal radiation of 188Re-lipid nanocapsules in an immunocompromised human glioblastoma model.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  525. RALEIGH DR, Tomlin B, Buono BD, Roddy E, et al
    Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patients.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  526. MAGILL ST, Theodosopoulos PV, McDermott MW
    Resection of falx and parasagittal meningioma: complication avoidance.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  527. INDINI A, Schiavello E, Biassoni V, Bergamaschi L, et al
    Long-term safety of growth hormone replacement therapy after childhood medulloblastoma and PNET: it is time to set aside old concerns.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  528. ARVOLD ND, Cefalu M, Wang Y, Zigler C, et al
    Comparative effectiveness of radiotherapy with vs. without temozolomide in older patients with glioblastoma.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  529. GILBERT MR, Pugh SL, Aldape K, Sorensen AG, et al
    NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  530. MALLAWAARATCHY DM, Hallal S, Russell B, Ly L, et al
    Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  531. SVENSSON A, Ramos-Moreno T, Eberstal S, Scheding S, et al
    Identification of two distinct mesenchymal stromal cell populations in human malignant glioma.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  532. DELLA PUPPA A, Lombardi G, Rossetto M, Rustemi O, et al
    Outcome of patients affected by newly diagnosed glioblastoma undergoing surgery assisted by 5-aminolevulinic acid guided resection followed by BCNU wafers implantation: a 3-year follow-up.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  533. TIVNAN A, Heilinger T, Lavelle EC, Prehn JH, et al
    Advances in immunotherapy for the treatment of glioblastoma.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  534. LIN AL, White M, Miller-Thomas MM, Fulton RS, et al
    Molecular and histologic characteristics of pseudoprogression in diffuse gliomas.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  535. HEMPEL JM, Bisdas S, Schittenhelm J, Brendle C, et al
    Erratum to: In vivo molecular profiling of human glioma using diffusion kurtosis imaging.
    J Neurooncol. 2016.
    PubMed     Text format    


  536. CHABOT P, Hsia TC, Ryu JS, Gorbunova V, et al
    Veliparib in combination with whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer: results of a randomized, global, placebo-controlled study.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  537. MISTRY AM, Hale AT, Chambless LB, Weaver KD, et al
    Influence of glioblastoma contact with the lateral ventricle on survival: a meta-analysis.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  538. ZHU Y, Qiu Z, Zhang X, Qian F, et al
    Jab1 promotes glioma cell proliferation by regulating Siah1/beta-catenin pathway.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  539. WANG Y, Deng J, Guo G, Tong A, et al
    Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  540. HICKMANN AK, Hechtner M, Nadji-Ohl M, Janko M, et al
    Evaluating patients for psychosocial distress and supportive care needs based on health-related quality of life in primary brain tumors: a prospective multicenter analysis of patients with gliomas in an outpatient setting.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  541. CONROY S, Wagemakers M, Walenkamp AM, Kruyt FA, et al
    Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  542. HAN SJ, Reis G, Kohanbash G, Shrivastav S, et al
    Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  543. POLLACK IF, Jakacki RI, Butterfield LH, Hamilton RL, et al
    Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  544. AABERG-JESSEN C, Halle B, Jensen SS, Muller S, et al
    Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  545. BUJKO M, Kober P, Rusetska N, Wakula M, et al
    Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  546. MARATHE K, McVicar N, Li A, Bellyou M, et al
    Topiramate induces acute intracellular acidification in glioblastoma.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


  547. YANAGIHARA TK, Saadatmand HJ, Wang TJ
    Reevaluating stereotactic radiosurgery for glioblastoma: new potential for targeted dose-escalation.
    J Neurooncol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  548. LIM J, Cho K
    The modified lateral supraorbital approach for tumors of the petroclival junction extending into the anterior cerebellopontine area.
    J Neurooncol. 2016;127:541-50.
    PubMed     Text format     Abstract available


  549. SAVELLI G, Bartolomei M, Bignardi M
    Somatostatin receptors imaging and therapy in a patient affected by esthesioneuroblastoma with meningeal metastases. A classic example of theranostic approach.
    J Neurooncol. 2016;127:617-9.
    PubMed     Text format    


  550. BECKER J, Steinmann E, Konemann M, Gabske S, et al
    Cognitive screening in patients with intracranial tumors: validation of the BCSE.
    J Neurooncol. 2016;127:559-67.
    PubMed     Text format     Abstract available


  551. VAN DE NES J, Gessi M, Sucker A, Moller I, et al
    Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
    J Neurooncol. 2016;127:435-44.
    PubMed     Text format     Abstract available


    February 2016
  552. MULDOON LL, Pagel MA, Netto JP, Neuwelt EA, et al
    Intra-arterial administration improves temozolomide delivery and efficacy in a model of intracerebral metastasis, but has unexpected brain toxicity.
    J Neurooncol. 2016;126:447-54.
    PubMed     Text format     Abstract available


  553. LOSA M, Bogazzi F, Cannavo S, Ceccato F, et al
    Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas.
    J Neurooncol. 2016;126:519-25.
    PubMed     Text format     Abstract available


  554. CHAMBERLAIN MC
    High-dose cytarabine salvage therapy for recurrent primary CNS lymphoma.
    J Neurooncol. 2016;126:545-50.
    PubMed     Text format     Abstract available


  555. TAIEB D, Barlier A, Yang C, Pertuit M, et al
    Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas.
    J Neurooncol. 2016;126:473-81.
    PubMed     Text format     Abstract available


    January 2016
  556. WALBERT T, Glantz M, Schultz L, Puduvalli VK, et al
    Impact of provider level, training and gender on the utilization of palliative care and hospice in neuro-oncology: a North-American survey.
    J Neurooncol. 2016;126:337-45.
    PubMed     Text format     Abstract available


  557. GILARD V, Alexandru C, Proust F, Derrey S, et al
    Pituitary metastasis: is there still a place for neurosurgical treatment?
    J Neurooncol. 2016;126:219-24.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: